| 1 |
Çelik F, Şenkaya A. İKİNCİ BASAMAK DEVLET HASTANESİNDE İKİ FARKLI HELICOBACTER PYLORI TEDAVİ REJİMİNİN ETKİNLİĞİNİN DEĞERLENDİRİLMESİ. TJHSL 2023. [DOI: 10.56150/tjhsl.1246441] [Reference Citation Analysis]
|
| 2 |
Karmakar BC, Paul S, Basak S, Ghosh M, Mukherjee P, Das R, Chaudhuri S, Dutta S, Mukhopadhyay AK. Development and evaluation of a simple PCR assay and nested PCR for rapid detection of clarithromycin-resistant Helicobacter pylori from culture and directly from the biopsy samples in India. Gut Pathog 2023;15:7. [PMID: 36782212 DOI: 10.1186/s13099-023-00530-7] [Reference Citation Analysis]
|
| 3 |
Aziz F, Kazmi SU. Thin Layer Immunoassay: An Economical Approach to Diagnose Helicobacter pylori Infection in Gastroduodenal Ulcer Disease Patients of Pakistan, a Comparative Analysis. Diagnostics (Basel) 2023;13. [PMID: 36766622 DOI: 10.3390/diagnostics13030517] [Reference Citation Analysis]
|
| 4 |
Galoș F, Boboc C, Ieșanu MI, Anghel M, Ioan A, Iana E, Coșoreanu MT, Boboc AA. Antibiotic Resistance and Therapeutic Efficacy of Helicobacter pylori Infection in Pediatric Patients-A Tertiary Center Experience. Antibiotics (Basel) 2023;12. [PMID: 36671347 DOI: 10.3390/antibiotics12010146] [Reference Citation Analysis]
|
| 5 |
Dascălu RI, Bolocan A, Păduaru DN, Constantinescu A, Mitache MM, Stoica AD, Andronic O. Multidrug resistance in Helicobacter pylori infection. Front Microbiol 2023;14:1128497. [PMID: 36922977 DOI: 10.3389/fmicb.2023.1128497] [Reference Citation Analysis]
|
| 6 |
Mestrovic A, Perkovic N, Tonkic A, Sundov Z, Kumric M, Bozic J. Personalized Approach in Eradication of Helicobacter pylori Infection. Antibiotics (Basel) 2022;12. [PMID: 36671208 DOI: 10.3390/antibiotics12010007] [Reference Citation Analysis]
|
| 7 |
Yunusa I, Love BL. Cost-Effectiveness of Vonoprazan- and Rifabutin-Based vs. Other Regimens as First-Line Treatment of Helicobacter Pylori Infection in the United States. Am J Gastroenterol 2022. [PMID: 36693030 DOI: 10.14309/ajg.0000000000002146] [Reference Citation Analysis]
|
| 8 |
Zhou J, Shen Y, Song X, Zhou L, Tang H, Li H. Evaluation of a Molecular Mosprie Assay for Detection of Helicobacter pylori and Resistance to Clarithromycin and Levofloxacin. J Infect Dis 2022;226:S503-9. [PMID: 36478246 DOI: 10.1093/infdis/jiac402] [Reference Citation Analysis]
|
| 9 |
Tang X, Shen Y, Song X, Benghezal M, Marshall BJ, Tang H, Li H. Reassessment of the Broth Microdilution Method for Susceptibility Testing of Helicobacter pylori. J Infect Dis 2022;226:S486-92. [PMID: 36478248 DOI: 10.1093/infdis/jiac389] [Reference Citation Analysis]
|
| 10 |
Hu Y, Wang Y, Mi M, Deng Z, Zhu J, Liu Q, Chen X, Chen Z. Correlation analysis of gastric mucosal lesions with Helicobacter pylori infection and its virulence genotype in Guiyang, Guizhou province, China. Ann Transl Med 2022;10:1320. [PMID: 36660645 DOI: 10.21037/atm-22-5553] [Reference Citation Analysis]
|
| 11 |
Kismat S, Tanni NN, Akhtar R, Roy CK, Rahman MM, Molla MMA, Anwar S, Ahmed S. Diagnosis and Comparison of Three Invasive Detection Methods for Helicobacter pylori Infection. Microbiol Insights 2022;15:11786361221133947. [PMID: 36325107 DOI: 10.1177/11786361221133947] [Reference Citation Analysis]
|
| 12 |
Sousa C, Ferreira R, Santos SB, Azevedo NF, Melo LDR. Advances on diagnosis of Helicobacter pylori infections. Crit Rev Microbiol 2022;:1-22. [PMID: 36264672 DOI: 10.1080/1040841X.2022.2125287] [Reference Citation Analysis]
|
| 13 |
Metwally M, Ragab R, Abdel Hamid HS, Emara N, Elkholy H. Helicobacter pylori Antibiotic Resistance in Egypt: A Single-Center Study. Infect Drug Resist 2022;15:5905-13. [PMID: 36312439 DOI: 10.2147/IDR.S386082] [Reference Citation Analysis]
|
| 14 |
Alsohaibani F, Peedikayil M, Alshahrani A, Somily A, Alsulaiman R, Azzam N, Almadi M. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi J Gastroenterol 2022. [PMID: 36204804 DOI: 10.4103/sjg.sjg_288_22] [Reference Citation Analysis]
|
| 15 |
Goni E, Tammer I, Schütte K, Thon C, Jechorek D, Mahajan UM, Vasapolli R, Macke L, Aulinger B, Selgrad M, Link A, Malfertheiner P, Schulz C. The influence of gastric atrophy on Helicobacter pylori antibiotics resistance in therapy-naïve patients. Front Microbiol 2022;13:938676. [DOI: 10.3389/fmicb.2022.938676] [Reference Citation Analysis]
|
| 16 |
Jiang Z, Qian X, Wang Z, Dong Y, Pan Y, Zhang Z, Wang S. Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021. Front Cell Infect Microbiol 2022;12:970630. [DOI: 10.3389/fcimb.2022.970630] [Reference Citation Analysis]
|
| 17 |
Nhu LTT, Nguyen VL, Tran VD, Tran NA, Nguyen VT. Evaluation of the Antibiotic Resistance Rate of Helicobacter pylori in Peptic Ulcer Patients in Tien Giang Central General Hospital, Tien Giang Province, Vietnam. Open Access Maced J Med Sci 2022;10:1835-1839. [DOI: 10.3889/oamjms.2022.10216] [Reference Citation Analysis]
|
| 18 |
Ho JJC, Navarro M, Sawyer K, Elfanagely Y, Moss SF. Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2022;117:1221-30. [PMID: 35509128 DOI: 10.14309/ajg.0000000000001828] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 19 |
Kermanshahian K, Yadegar A, Moghimi H, Ghourchian H. The synergy of Fe3O4@Au and molybdate as HRP-Mimetic catalysts for gold nanorods etching: development of an ultrasensitive genosensor for detection of Helicobacter pylori. Sensors and Actuators B: Chemical 2022. [DOI: 10.1016/j.snb.2022.132600] [Reference Citation Analysis]
|
| 20 |
Pei Y, Ang D, Kwek ABE, Ang TL. The changing profile of Helicobacter pylori primary antibiotic resistance in Singapore over two decades. J Dig Dis 2022. [PMID: 35849105 DOI: 10.1111/1751-2980.13115] [Reference Citation Analysis]
|
| 21 |
Nemr N, Kishk RM, Salem A, Abdalla MO, Abd El-Fadeal NM, Soliman NM. Genotypic detection of metronidazole and clarithromycin resistance in dyspeptic patients with helicobacter pylori. Environ Sci Pollut Res Int 2022;29:41467-74. [PMID: 35088259 DOI: 10.1007/s11356-021-18198-4] [Reference Citation Analysis]
|
| 22 |
El Hafa F, Wang T, Ndifor VM, Jin G. Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: A meta-analysis. Helicobacter 2022;27:e12881. [PMID: 35212073 DOI: 10.1111/hel.12881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Niu M, Zhou Y, Xie Y, Li X, Tian Y, Yao L, Li X, Gao H, Bai F. Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori. Front Pharmacol 2022;13:771876. [PMID: 35571120 DOI: 10.3389/fphar.2022.771876] [Reference Citation Analysis]
|
| 24 |
Durak D, Turhan VB, Alkurt EG, Köseoğlu H. Investigation of the frequency of helicobacter pylori, chronic gastritis and gastric cancer observed in the stomach in the local population. Turkish Journal of Clinics and Laboratory 2022. [DOI: 10.18663/tjcl.1093053] [Reference Citation Analysis]
|
| 25 |
Knoop RF, Gaertner PC, Petzold G, Amanzada A, Ellenrieder V, Neesse A, Bremer SCB, Kunsch S, Mascellino MT. Systematic Retesting for Helicobacter pylori: The Potential Overestimation of Suppressive Conditions. BioMed Research International 2022;2022:1-6. [DOI: 10.1155/2022/5380001] [Reference Citation Analysis]
|
| 26 |
Nestegard O, Moayeri B, Halvorsen F, Tønnesen T, Sørbye SW, Paulssen E, Johnsen K, Goll R, Florholmen JR, Melby KK. Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure. PLoS ONE 2022;17:e0265322. [DOI: 10.1371/journal.pone.0265322] [Reference Citation Analysis]
|
| 27 |
Ansari S, Yamaoka Y. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance. Clin Microbiol Rev 2022;:e0025821. [PMID: 35404105 DOI: 10.1128/cmr.00258-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Chang YW, Shin GY, Kim JW, Moon JC, Chang EJ, Oh CH, Jang JY. Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication. Dig Dis Sci 2022;67:1222-30. [PMID: 33755825 DOI: 10.1007/s10620-021-06938-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 29 |
Li H, Shen Y, Song X, Tang X, Hu R, Marshall BJ, Tang H, Benghezal M. Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing. Helicobacter 2022;27:e12873. [PMID: 35151236 DOI: 10.1111/hel.12873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 30 |
Vanden Bulcke A, Waked B, Haems L, Lambrecht G, Hervent AS, Alliet G, Baert F, Vervaeke S. Antimicrobial resistance of Helicobacter pylori in West Flanders - Belgium: an observational cross-sectional study. Acta Clin Belg 2022;77:360-7. [PMID: 33502281 DOI: 10.1080/17843286.2021.1872307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Hou C, Yin F, Wang S, Zhao A, Li Y, Liu Y. Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents. IDR 2022;Volume 15:1561-71. [DOI: 10.2147/idr.s357473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Guo Z, Tian S, Wang W, Zhang Y, Li J, Lin R. Correlation Analysis Among Genotype Resistance, Phenotype Resistance, and Eradication Effect After Resistance-Guided Quadruple Therapies in Refractory Helicobacter pylori Infections. Front Microbiol 2022;13:861626. [PMID: 35330762 DOI: 10.3389/fmicb.2022.861626] [Reference Citation Analysis]
|
| 33 |
Shakir SM, Otiso J, Keller G, Heule HV, Osborn LJ, Cole N, Schuetz AN, Richter SS, Couturier MR, Lainhart W. Multicenter Evaluation of a Gradient Diffusion Method for Antimicrobial Susceptibility Testing of Helicobacter pylori. Microbiol Spectr. [DOI: 10.1128/spectrum.02111-21] [Reference Citation Analysis]
|
| 34 |
Tanni NN, Ahmed S, Anwar S, Kismat S, Halder K, Nesa M, Habib FB. Endoscopic and histopathological findings in adult dyspeptic patients, and their association with Helicobacter pylori infection in Dhaka, Bangladesh. IJID Regions 2022;2:30-34. [DOI: 10.1016/j.ijregi.2021.11.006] [Reference Citation Analysis]
|
| 35 |
Cardos AI, Maghiar A, Zaha DC, Pop O, Fritea L, Miere (Groza) F, Cavalu S. Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools. Diagnostics 2022;12:508. [DOI: 10.3390/diagnostics12020508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 36 |
Fatemi Khader M, Pourmahdi Borujeni M, Moori Bakhtiari N, Avizeh R. An exploratory study on the presence of Helicobacter heilmannii and Helicobacter billis in the faces of companion dogs. Veterinary Medicine & Sci. [DOI: 10.1002/vms3.765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Ding SZ, Du YQ, Lu H, Wang WH, Cheng H, Chen SY, Chen MH, Chen WC, Chen Y, Fang JY, Gao HJ, Guo MZ, Han Y, Hou XH, Hu FL, Jiang B, Jiang HX, Lan CH, Li JN, Li Y, Li YQ, Liu J, Li YM, Lyu B, Lu YY, Miao YL, Nie YZ, Qian JM, Sheng JQ, Tang CW, Wang F, Wang HH, Wang JB, Wang JT, Wang JP, Wang XH, Wu KC, Xia XZ, Xie WF, Xie Y, Xu JM, Yang CQ, Yang GB, Yuan Y, Zeng ZR, Zhang BY, Zhang GY, Zhang GX, Zhang JZ, Zhang ZY, Zheng PY, Zhu Y, Zuo XL, Zhou LY, Lyu NH, Yang YS, Li ZS; National Clinical Research Center for Digestive Diseases (Shanghai), Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA), Helicobacter pylori Study Group of Chinese Society of Gastroenterology, and Chinese Alliance for Helicobacter pylori Study. Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition). Gut 2022;71:238-53. [PMID: 34836916 DOI: 10.1136/gutjnl-2021-325630] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 38 |
Brennan DE, O'Morain C, McNamara D, Smith SM. Combined antrum and corpus biopsy protocol improves Helicobacter pylori culture success. World J Gastrointest Pathophysiol 2022; 13(1): 34-40 [DOI: 10.4291/wjgp.v13.i1.34] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
El-sherbiny GM, Elbestawy MKM. A review – plant essential oils active against Helicobacter pylori. Journal of Essential Oil Research. [DOI: 10.1080/10412905.2022.2025464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 40 |
Skrebinska S, Megraud F, Daugule I, Santare D, Isajevs S, Liepniece-Karele I, Bogdanova I, Rudzite D, Vangravs R, Kikuste I, Vanags A, Tolmanis I, Savcenko S, Alix C, Herrero R, Park JY, Leja M. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection? Diagnostics (Basel) 2022;12:133. [PMID: 35054298 DOI: 10.3390/diagnostics12010133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 41 |
Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 2022. [PMID: 34988937 DOI: 10.1007/s42770-021-00675-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 42 |
Keikha M, Sahebkar A, Yamaoka Y, Karbalaei M. Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis. J Health Popul Nutr 2022;41:2. [PMID: 34980267 DOI: 10.1186/s41043-021-00280-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 43 |
Vaiphei K. Demonstration of Helicobacter pylori (HP) and Other Related Organisms. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_6] [Reference Citation Analysis]
|
| 44 |
Lormohammadi L, Nikkhahi F, Bolori S, Karami AA, Hajian S, Rad N, Peymani A, Samimi R. High level of resistance to metronidazole and clarithromycin among Helicobacter pylori clinical isolates in Qazvin province, Iran. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101494] [Reference Citation Analysis]
|
| 45 |
Nayim P, Mbaveng AT, Kuete V. Anti-Helicobacter pylori activities of African medicinal plants. Advances in Botanical Research 2022. [DOI: 10.1016/bs.abr.2022.08.010] [Reference Citation Analysis]
|
| 46 |
Vagarali MA, Metgud SC, Bannur H, Dodamani SS. A Cross-Sectional Study on Molecular Detection of Helicobacter pylori cytotoxin-associated gene A and 16SrRNA Gene from Gastric Biopsy Specimens. J Glob Infect Dis 2021;13:120-5. [PMID: 34703151 DOI: 10.4103/jgid.jgid_60_20] [Reference Citation Analysis]
|
| 47 |
Grande R, Carradori S, Puca V, Vitale I, Angeli A, Nocentini A, Bonardi A, Gratteri P, Lanuti P, Bologna G, Simeone P, Capasso C, De Luca V, Supuran CT. Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles. Int J Mol Sci 2021;22:11583. [PMID: 34769015 DOI: 10.3390/ijms222111583] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 48 |
Erkut M, Uzun DY, Kaklıkkaya N, Fidan S, Yoğun Y, Coşar AM, Akyıldız E, Topbaş M, Özgür O, Arslan M. Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. Turk J Gastroenterol 2020;31:221-33. [PMID: 32343234 DOI: 10.5152/tjg.2020.18631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 49 |
Chen LW, Chang LC, Hua CC, Liu CJ, Chou TS, Lin CL, Chien RN. The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial. J Clin Med 2021;10:4352. [PMID: 34640370 DOI: 10.3390/jcm10194352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 50 |
Huang X, Liu Y, Lin Z, Wu B, Nong G, Chen Y, Lu Y, Ji X, Zhou X, Suo B, Chen Q, Wei J. Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China. PLoS One 2021;16:e0256225. [PMID: 34473713 DOI: 10.1371/journal.pone.0256225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 51 |
Taghvaei T, Kamali N, Talebi Bezmin Abadi A, Rahimi F, Forootan M. Isolation of dupA-positive and clarithromycin-resistant Helicobacter pylori from Iranian patients with duodenal ulcer. Gene Reports 2021;24:101228. [DOI: 10.1016/j.genrep.2021.101228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 52 |
Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol 2021;18:613-29. [PMID: 34002081 DOI: 10.1038/s41575-021-00449-x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 37.5] [Reference Citation Analysis]
|
| 53 |
Akeel M, Elhafey A, Shehata A, Elmakki E, Aboshouk T, Ageely H, Mahfouz MS. Efficacy of immunohistochemical staining in detecting <em>Helicobacter pylori</em> in Saudi patients with minimal and atypical infection. Eur J Histochem 2021;65. [PMID: 34284564 DOI: 10.4081/ejh.2021.3222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 54 |
Kim SY, Park JM, Lim CH, Lee HA, Shin GY, Choe Y, Cho YK, Choi MG. Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori. Gut Liver 2021;15:528-36. [PMID: 33376228 DOI: 10.5009/gnl20225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Kim JJE, Kocsmár I, Buzás GM, Szirtes I, Rusz O, Diczházi C, Szijártó A, Hritz I, Schaff Z, Kiss A, Kocsmár É, Lotz G. Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study. Pathol Oncol Res 2021;27:1609863. [PMID: 34267605 DOI: 10.3389/pore.2021.1609863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Gastli N, Allain M, Lamarque D, Abitbol V, Billoët A, Collobert G, Coriat R, Terris B, Kalach N, Raymond J. Diagnosis of Helicobacter pylori Infection in a Routine Testing Workflow: Effect of Bacterial Load and Virulence Factors. J Clin Med 2021;10:2755. [PMID: 34201588 DOI: 10.3390/jcm10132755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 57 |
Puah SM, Goh KL, Ng HK, Chua KH. Current status of Helicobacter pylori resistance to Clarithromycin and Levofloxacin in Malaysia-findings from a molecular based study. PeerJ 2021;9:e11518. [PMID: 34178444 DOI: 10.7717/peerj.11518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 58 |
Perkovic N, Mestrovic A, Bozic J, Ivelja MP, Vukovic J, Kardum G, Sundov Z, Tonkic M, Puljiz Z, Vukojevic K, Tonkic A. Randomized Clinical Trial Comparing Concomitant and Tailored Therapy for Eradication of Helicobacter pylori Infection. J Pers Med 2021;11:534. [PMID: 34207870 DOI: 10.3390/jpm11060534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 59 |
Mirzaei S, Keshavarzi F, Karami P, Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran, Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran, Department of Medical Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. The Prevalence of H. Pylori cagA Gene in Patients with Gastric Ulcer. Iran J Med Microbiol 2021;15:345-351. [DOI: 10.30699/ijmm.15.3.345] [Reference Citation Analysis]
|
| 60 |
Van den Poel B, Gils S, Micalessi I, Carton S, Christiaens P, Cuyle PJ, Moons V, Van Olmen G, Smismans A, Bourgain C, Bossuyt P, Frans J. Molecular detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies: a prospective evaluation of RIDA®GENE Helicobacter pylori assay. Acta Clin Belg 2021;76:177-83. [PMID: 31662122 DOI: 10.1080/17843286.2019.1685741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 61 |
Marrero Rolon R, Cunningham SA, Mandrekar JN, Polo ET, Patel R. Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool. J Clin Microbiol 2021;59:e03040-20. [PMID: 33536295 DOI: 10.1128/JCM.03040-20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 62 |
Mannion A, Dzink-Fox J, Shen Z, Piazuelo MB, Wilson KT, Correa P, Peek RM Jr, Camargo MC, Fox JG. Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations. J Clin Microbiol 2021;59:e03203-20. [PMID: 33692136 DOI: 10.1128/JCM.03203-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 63 |
Li SY, Kao CC, Hu YC, Lai CH, Jiang YP, Mao YC, Huang YT, Liu PY. Arthrobacter woluwensis Bacteremia: A Clinical and Genomic Report. Pathogens 2021;10:443. [PMID: 33917709 DOI: 10.3390/pathogens10040443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 64 |
Mi M, Wu F, Zhu J, Liu F, Cui G, Wen X, Hu Y, Deng Z, Wu X, Zhang Z, Qi T, Chen Z. Heterogeneity of Helicobacter pylori Strains Isolated from Patients with Gastric Disorders in Guiyang, China. Infect Drug Resist 2021;14:535-45. [PMID: 33603417 DOI: 10.2147/IDR.S287631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 65 |
Wu H, Gu L, Ma X, Tian X, Fan S, Qin M, Lu J, Lyu M, Wang S. Rapid Detection of Helicobacter pylori by the Naked Eye Using DNA Aptamers. ACS Omega 2021;6:3771-9. [PMID: 33585756 DOI: 10.1021/acsomega.0c05374] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 66 |
Albasha AM, Elnosh MM, Osman EH, Zeinalabdin DM, Fadl AAM, Ali MA, Altayb HN. Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patients. BMC Microbiol 2021;21:38. [PMID: 33535966 DOI: 10.1186/s12866-021-02096-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Mégraud F, Alix C, Charron P, Bénéjat L, Ducournau A, Bessède E, Lehours P. Survey of the antimicrobial resistance of Helicobacter pylori in France in 2018 and evolution during the previous 5 years. Helicobacter 2021;26:e12767. [PMID: 33090614 DOI: 10.1111/hel.12767] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 68 |
Gong RJ, Xu CX, Li H, Liu XM. Polymerase chain reaction-based tests for detecting Helicobacter pylori clarithromycin resistance in stool samples: A meta-analysis. World J Clin Cases 2021; 9(1): 133-147 [PMID: 33511178 DOI: 10.12998/wjcc.v9.i1.133] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 69 |
Meriem Z, Elmekkaoui A, Bouqfar M, Zazour A, Khannoussi W, Kharrasse G, Abda N, Ismaili Z. Non-Bismuth Quadruple Therapy, Sequential Therapy or High-Dose Esomeprazole and Amoxicillin Dual Therapy for First-Line Helicobacter pylori Eradication: A Prospective Randomized Study. Cureus 2020. [DOI: 10.7759/cureus.11837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 70 |
Cerri G, Farina M, Brundu A, Gavini E, Salis A, Dathe W. Antibacterial activity of Zn-loaded Cuban zeolite against Helicobacter pylori in comparison to its Na-loaded and unmodified counterparts. Environ Geochem Health 2021;43:2037-48. [PMID: 33244649 DOI: 10.1007/s10653-020-00781-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 71 |
Arj A, Mollaei M, Razavizadeh M, Moraveji A. The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication. J Res Pharm Pract 2020;9:101-5. [PMID: 33102384 DOI: 10.4103/jrpp.JRPP_19_86] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 72 |
Atehortua Rendon JD, Pérez Cala TL, Martínez A. Descripción de la resistencia de Helicobacter pylori a seis antibióticos de uso frecuente en Colombia. Rev Colomb Gastroenterol 2020;35:351-361. [DOI: 10.22516/25007440.493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 73 |
Nestegard O, Johnsen KM, Sørbye SW, Halvorsen FA, Tønnessen T, Paulssen EJ, Melby KK, Goll R, Florholmen J. Clinical characterization of Helicobacter pylori infected patients 15 years after unsuccessful eradication. PLoS One 2020;15:e0238944. [PMID: 32966303 DOI: 10.1371/journal.pone.0238944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 74 |
Miftahussurur M. Noninvasive Helicobacter pylori Diagnostic Methods in Indonesia. Gut Liver 2020;14:553-9. [PMID: 31693853 DOI: 10.5009/gnl19264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 75 |
Kim HU. Helicobacter pylori Eradication Therapy - Recent Trend in Research. Korean J Helicobacter Up Gastrointest Res 2020;20:210-217. [DOI: 10.7704/kjhugr.2019.0051] [Reference Citation Analysis]
|
| 76 |
Park CG, Kim S, Jeon HS, Han S. Validation of loop-mediated isothermal amplification to detect Helicobacter pylori and 23S rRNA mutations: A prospective, observational clinical cohort study. J Clin Lab Anal 2021;35:e23563. [PMID: 32893424 DOI: 10.1002/jcla.23563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 77 |
Alihosseini S, Jaberinezhad M, Sadeghpourheravi F, Ghotaslou R, Ebrahimzadeh Leylabadlo H. Invasive and non-invasive Helicobacter pylori diagnostic methods in Iran. Gene Reports 2020;20:100749. [DOI: 10.1016/j.genrep.2020.100749] [Reference Citation Analysis]
|
| 78 |
Jehanne Q, Bénéjat L, Mégraud F, Bessède E, Lehours P. Evaluation of the Allplex™ H pylori and ClariR PCR Assay for Helicobacter pylori detection on gastric biopsies. Helicobacter 2020;25:e12702. [PMID: 32426894 DOI: 10.1111/hel.12702] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 79 |
Seo KI, Heo JJ, Kim SE, Park SJ, Park MI, Moon W, Kim JH, Jung K, Cho DH. Sex differences between Helicobacter pylori infection and cholesterol levels in an adult health checkup program. Helicobacter 2020;25:e12704. [PMID: 32458524 DOI: 10.1111/hel.12704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 80 |
Saleem N, Howden CW. Update on the Management of Helicobacter pylori Infection. Curr Treat Options Gastroenterol 2020;:1-12. [PMID: 32837180 DOI: 10.1007/s11938-020-00300-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 81 |
Guevara B, Cogdill AG. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies. Dig Dis Sci 2020;65:1917-31. [PMID: 32170476 DOI: 10.1007/s10620-020-06193-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 82 |
Liou JM, Lee YC, Wu MS. Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota. J Gastroenterol Hepatol 2020;35:1107-16. [PMID: 31984532 DOI: 10.1111/jgh.14992] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 83 |
Kim SE, Memon A, Kim BY, Jeon H, Lee WK, Kang SC. Gastroprotective effect of phytoncide extract from Pinus koraiensis pinecone in Helicobacter pylori infection. Sci Rep 2020;10:9547. [PMID: 32533032 DOI: 10.1038/s41598-020-66603-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 84 |
Carpenter GH. Salivary Factors that Maintain the Normal Oral Commensal Microflora. J Dent Res 2020;99:644-9. [PMID: 32283990 DOI: 10.1177/0022034520915486] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 85 |
Boyanova L, Markovska R, Medeiros J, Gergova G, Mitov I. Delafloxacin against Helicobacter pylori, a potential option for improving eradication success? Diagnostic Microbiology and Infectious Disease 2020;96:114980. [DOI: 10.1016/j.diagmicrobio.2019.114980] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 86 |
Vilaichone RK, Aumpan N, Ratanachu-Ek T, Gamnarai P, Uchida T, Tshering L, Mahachai V, Yamaoka Y. Efficacy of Omeprazole, Tetracycline, and 4 Times Daily Dosing of Amoxicillin in Helicobacter pylori Eradication in Limited Resource Area in Bhutan: A Prospective Randomized Trial (BHUTAN Study). Asian Pac J Cancer Prev 2020;21:1109-14. [PMID: 32334478 DOI: 10.31557/APJCP.2020.21.4.1109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 87 |
Pichon M, Pichard B, Barrioz T, Plouzeau C, Croquet V, Fotsing G, Chéron A, Vuillemin É, Wangermez M, Haineaux PA, Vasseur P, Thiebault Q, Lefèvre C, de Singly A, Cremniter J, Broutin L, Michaud A, Silvain C, Burucoa C. Diagnostic Accuracy of a Noninvasive Test for Detection of Helicobacter pylori and Resistance to Clarithromycin in Stool by the Amplidiag H. pylori+ClariR Real-Time PCR Assay. J Clin Microbiol 2020;58:e01787-19. [PMID: 31996442 DOI: 10.1128/JCM.01787-19] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 88 |
Kocsmár É, Kocsmár I, Buzás GM, Szirtes I, Wacha J, Takáts A, Hritz I, Schaff Z, Rugge M, Fassan M, Kiss A, Lotz G. Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept. Helicobacter 2020;25:e12670. [PMID: 31701608 DOI: 10.1111/hel.12670] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 89 |
Zhang Y, Wen Y, Xiao Q, Zheng W, Long G, Chen B, Shu X, Jiang M. Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China. Infect Drug Resist 2020;13:311-22. [PMID: 32099422 DOI: 10.2147/IDR.S235615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 90 |
Lee YI, Kim JS, Cho JS, Kim HK, Hussain A. Standardized Combined Plant Extract, RUG-com, Reduces Bacterial Levels and Suppresses Acute and Chronic Inflammation in Balb/c Mice Infected with CagA+ Helicobacter pylori.. Prev Nutr Food Sci 2019;24:426-33. [PMID: 31915638 DOI: 10.3746/pnf.2019.24.4.426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 91 |
Aziz F, Taj Y, Kazmi SU. Thin layer immunoassay; an economical approach to diagnoseHelicobacter pyloriInfection in gastroduodenal ulcer disease patients of Pakistan; a comparative analysis.. [DOI: 10.1101/2020.01.05.895375] [Reference Citation Analysis]
|
| 92 |
Georgopoulos SD, Michopoulos S, Rokkas T, Apostolopoulos P, Giamarellos E, Kamberoglou D, Mentis A, Triantafyllou K. Hellenic consensus on Helicobacter pylori infection. Ann Gastroenterol 2020;33:105-24. [PMID: 32127732 DOI: 10.20524/aog.2020.0446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 93 |
Megraud F, Lehours P. Helicobacter pylori. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65770-7] [Reference Citation Analysis]
|
| 94 |
Rezaei S, Talebi Bezmin Abadi A, Mohabatti Mobarez A. Metronidazole-resistant Helicobacter pylori isolates without rdxA mutations obtained from Iranian dyspeptic patients. New Microbes New Infect 2020;34:100636. [PMID: 31993205 DOI: 10.1016/j.nmni.2019.100636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 95 |
Fan CC, Chen CH, Chou C, Kao TY, Cheng AN, Lee AY, Kuo CL. A time-saving-modified Giemsa stain is a better diagnostic method of Helicobacter pylori infection compared with the rapid urease test. J Clin Lab Anal 2020;34:e23110. [PMID: 31733007 DOI: 10.1002/jcla.23110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 96 |
Maixner F, Thorell K, Granehäll L, Linz B, Moodley Y, Rattei T, Engstrand L, Zink A. Helicobacter pylori in ancient human remains. World J Gastroenterol 2019; 25(42): 6289-6298 [PMID: 31754290 DOI: 10.3748/wjg.v25.i42.6289] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 97 |
Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S 3rd, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018;67:e1-e94. [PMID: 29955859 DOI: 10.1093/cid/ciy381] [Cited by in Crossref: 200] [Cited by in F6Publishing: 219] [Article Influence: 50.0] [Reference Citation Analysis]
|
| 98 |
Farina M, Brundu A, Bonferoni MC, Juliano C, Rassu G, Gavini E, Cerri G. Antibacterial activity of Na-clinoptilolite against Helicobacter pylori: in-vitro tests, synergistic effect with amoxicillin and stability of the antibiotic formulated with the zeolite. Microporous and Mesoporous Materials 2019;288:109592. [DOI: 10.1016/j.micromeso.2019.109592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 99 |
Khani S, Talebi Bezmin Abadi A, Mohabati Mobarez A. Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients' Stomachs. Infect Drug Resist 2019;12:3415-20. [PMID: 31802920 DOI: 10.2147/IDR.S223602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 100 |
Morilla AM, Álvarez-argüelles ME, Duque JM, Armesto E, Villar H, Melón S. Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study. Gastroenterología y Hepatología (English Edition) 2019;42:476-485. [DOI: 10.1016/j.gastre.2019.05.003] [Reference Citation Analysis]
|
| 101 |
Pohl D, Keller PM, Bordier V, Wagner K. Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing. World J Gastroenterol 2019; 25(32): 4629-4660 [PMID: 31528091 DOI: 10.3748/wjg.v25.i32.4629] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 77] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 102 |
Mendoza-Elizalde S, Cortés-Márquez AC, Zuñiga G, Cerritos R, Valencia-Mayoral P, Sánchez AC, Olivares-Clavijo H, Velázquez-Guadarrama N. Inference from the analysis of genetic structure of Helicobacter pylori strains isolates from two paediatric patients with recurrent infection. BMC Microbiol 2019;19:184. [PMID: 31395006 DOI: 10.1186/s12866-019-1554-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 103 |
Korona-Glowniak I, Cichoz-Lach H, Siwiec R, Andrzejczuk S, Glowniak A, Matras P, Malm A. Antibiotic Resistance and Genotypes of Helicobacter pylori Strains in Patients with Gastroduodenal Disease in Southeast Poland. J Clin Med 2019;8:E1071. [PMID: 31330898 DOI: 10.3390/jcm8071071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 104 |
Ladrón-de-guevara L, Bornstein-quevedo L, González-huezo S, Castañeda-romero B, Costa F, di Silvio-lópez M. Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase IIIb trial. Revista de Gastroenterología de México (English Edition) 2019;84:274-283. [DOI: 10.1016/j.rgmxen.2018.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 105 |
Jaka H, Rüttgerodt N, Bohne W, Mueller A, Gross U, Kasang C, Mshana SE. Helicobacter pylori Mutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania. Can J Gastroenterol Hepatol 2019;2019:8481375. [PMID: 31355162 DOI: 10.1155/2019/8481375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 106 |
Nezami BG, Jani M, Alouani D, Rhoads DD, Sadri N. Helicobacter pylori Mutations Detected by Next-Generation Sequencing in Formalin-Fixed, Paraffin-Embedded Gastric Biopsy Specimens Are Associated with Treatment Failure. J Clin Microbiol. 2019;57:pii: e01834-18. [PMID: 31068413 DOI: 10.1128/jcm.01834-18] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 107 |
Fagan-Garcia K, Geary J, Chang HJ, McAlpine L, Walker E, Colquhoun A, van Zanten SV, Girgis S, Archie B, Hanley B, Corriveau A, Morse J, Munday R, Goodman KJ; CANHelp Working Group. Burden of disease from Helicobacter pylori infection in western Canadian Arctic communities. BMC Public Health 2019;19:730. [PMID: 31185961 DOI: 10.1186/s12889-019-7065-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 108 |
Arévalo A, Otero WA, Trespalacios AA. Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia. Biomedica 2019;39:125-34. [PMID: 31529855 DOI: 10.7705/biomedica.v39i3.4437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 109 |
Hsieh MS, Liu CJ, Hsu WH, Li CJ, Tsai PY, Hu HM, Shih HY, Lu CY, Yu FJ, Kuo FC, Wu DC, Kuo CH. Gastric juice-based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection. Helicobacter 2019;24:e12568. [PMID: 30821043 DOI: 10.1111/hel.12568] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 110 |
Cho JH, Jeon SR, Kim HG, Jin SY, Park S. Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients. J Gastroenterol Hepatol 2019;34:700-6. [PMID: 30011083 DOI: 10.1111/jgh.14383] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 111 |
Di Lodovico S, Napoli E, Di Campli E, Di Fermo P, Gentile D, Ruberto G, Nostro A, Marini E, Cellini L, Di Giulio M. Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains. Sci Rep 2019;9:4646. [PMID: 30874618 DOI: 10.1038/s41598-019-40991-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 112 |
Hashemi SJ, Sheikh AF, Goodarzi H, Yadyad MJ, Seyedian SS, Aslani S, Assarzadegan MA. Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders. Infect Drug Resist. 2019;12:535-543. [PMID: 30881059 DOI: 10.2147/idr.s192942] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 113 |
Macías-García F, Bastón-Rey I, de la Iglesia-García D, Calviño-Suárez C, Nieto-García L, Domínguez-Muñoz JE. Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial. Helicobacter 2019;24:e12546. [PMID: 30346636 DOI: 10.1111/hel.12546] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 114 |
Prasad A, Devi AT, Prasad MNN, Zameer F, Shruthi G, Shivamallu C. Phyto anti-biofilm elicitors as potential inhibitors of Helicobacter pylori. 3 Biotech 2019;9:53. [PMID: 30729077 DOI: 10.1007/s13205-019-1582-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 115 |
Yeo YH, Hsu CC, Lee CC, Ho HJ, Lin JT, Wu MS, Liou JM, Wu CY; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication. J Gastroenterol Hepatol 2019;34:59-67. [PMID: 30169908 DOI: 10.1111/jgh.14462] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 116 |
Boyanova L, Markovska R, Mitov I. Helicobacter pylori growth stimulation by adrenaline detected by two methods. Diagnostic Microbiology and Infectious Disease 2019;93:30-32. [DOI: 10.1016/j.diagmicrobio.2018.08.004] [Reference Citation Analysis]
|
| 117 |
Enespa, Chandra P. Fungal Community for Novel Secondary Metabolites. Recent Advancement in White Biotechnology Through Fungi 2019. [DOI: 10.1007/978-3-030-14846-1_9] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 118 |
Kamarehei F, Khabiri A, Saidijam M, Soleimani M, Alikhani MY. Designing a novel ELISA method based on CagA, NapA recombinant antigens to increase sensitivity and specificity of Helicobacter pylori whole cell antigen detection. Gastroenterol Hepatol Bed Bench 2018;11:333-42. [PMID: 30425813] [Reference Citation Analysis]
|
| 119 |
Guessoum M, Guechi Z, Adnane M. First-time serological and molecular detection of Helicobacter pylori in milk from Algerian local-breed cows. Vet World 2018;11:1326-30. [PMID: 30410241 DOI: 10.14202/vetworld.2018.1326-1330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 120 |
Khadka P, Chapagain G, Maharjan G, Paudyal P. A comparison of techniques to address the frequency of Helicobacter pylori positive dyspeptic patient. BMC Res Notes 2018;11:784. [PMID: 30390715 DOI: 10.1186/s13104-018-3897-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 121 |
Liou JM, Chen PY, Kuo YT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Toward population specific and personalized treatment of Helicobacter pylori infection. J Biomed Sci 2018;25:70. [PMID: 30285834 DOI: 10.1186/s12929-018-0471-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 122 |
Bénéjat L, Ducournau A, Lehours P, Mégraud F. Real-time PCR for Helicobacter pylori diagnosis. The best tools available. Helicobacter 2018;23:e12512. [PMID: 30156040 DOI: 10.1111/hel.12512] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 123 |
Silva GM, Silva HM, Nascimento J, Gonçalves JP, Pereira F, Lima R. Helicobacter pylori antimicrobial resistance in a pediatric population. Helicobacter 2018;23:e12528. [PMID: 30091503 DOI: 10.1111/hel.12528] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 124 |
Liou JM, Chen PY, Luo JC, Lee JY, Chen CC, Fang YJ, Yang TH, Chang CY, Bair MJ, Chen MJ, Hsu YC, Hsu WF, Chang CC, Lin JT, Shun CT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. Gastroenterology 2018;155:1109-19. [PMID: 29964036 DOI: 10.1053/j.gastro.2018.06.047] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 125 |
Park CG, Kim S, Lee EJ, Jeon HS, Han S. Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication: A prospective, observational study. Medicine (Baltimore) 2018;97:e11835. [PMID: 30113472 DOI: 10.1097/MD.0000000000011835] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 126 |
Tonkic A, Vukovic J, Vrebalov Cindro P, Pesutic Pisac V, Tonkic M. Diagnosis of Helicobacter pylori infection : A short review. Wien Klin Wochenschr 2018;130:530-4. [PMID: 29959527 DOI: 10.1007/s00508-018-1356-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 127 |
Coelho LG, Sant'Ana CR, Oliveira RB, Cezar RCE, Araujo ACC, Silva RCTD, Trindade OR, Coelho MC, Ferrioli E, Bendassolli JA. Performance of the 13C-urea breath test for the diagnosis of H. pylori infection using a substrate synthesized in Brazil: A preliminary study. Clinics (Sao Paulo). 2018;73:e16553. [PMID: 29898005 DOI: 10.6061/clinics/2018/e16-553] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 128 |
Talebi Bezmin Abadi A, Yamaoka Y. Call for shift in Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 2018;30:687. [PMID: 29697524 DOI: 10.1097/MEG.0000000000001096] [Reference Citation Analysis]
|
| 129 |
Kheyre H, Morais S, Ferro A, Costa AR, Norton P, Lunet N, Peleteiro B. The occupational risk of Helicobacter pylori infection: a systematic review. Int Arch Occup Environ Health 2018;91:657-74. [DOI: 10.1007/s00420-018-1315-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 130 |
Talebi Bezmin Abadi A. Diagnosis of Helicobacter pylori Using Invasive and Noninvasive Approaches. J Pathog 2018;2018:9064952. [PMID: 29951318 DOI: 10.1155/2018/9064952] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 131 |
Choi JH, Yang YJ, Bang CS, Lee JJ, Baik GH. Current Status of the Third-Line Helicobacter pylori Eradication. Gastroenterol Res Pract 2018;2018:6523653. [PMID: 29853863 DOI: 10.1155/2018/6523653] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 132 |
Wang YH, Li Z, Wang L, Zhu-Ge LY, Zhao RL, Wu S, Wang Y, An Y, Xie Y. A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori. Helicobacter 2018;23:e12467. [PMID: 29405526 DOI: 10.1111/hel.12467] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 133 |
Kashani N, Talebi Bezmin Abadi A. Optimised Helicobacter pylori antibiotic susceptibility profile using gold-standard method. Journal of Global Antimicrobial Resistance 2018;12:15-16. [DOI: 10.1016/j.jgar.2017.11.006] [Reference Citation Analysis]
|
| 134 |
Bachir M, Allem R, Tifrit A, Medjekane M, Drici AE, Diaf M, Douidi KT. Primary antibiotic resistance and its relationship with cagA and vacA genes in Helicobacter pylori isolates from Algerian patients. Braz J Microbiol. 2018;49:544-551. [PMID: 29452847 DOI: 10.1016/j.bjm.2017.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 135 |
Piroozmand A, Soltani B, Razavizadeh M, Matini AH, Gilasi HR, Zavareh AN, Soltani S. Comparison of the serum and salivary antibodies to detect gastric Helicobacter pylori infection in Kashan (Iran). Electron Physician 2017;9:6129-34. [PMID: 29560169 DOI: 10.19082/6129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 136 |
Kwon YH, Kim JY, Kim N, Park JH, Nam RH, Lee SM, Kim JW, Kim JM, Park JY, Lee DH. Specific mutations of penicillin-binding protein 1A in 77 clinically acquired amoxicillin-resistant Helicobacter pylori strains in comparison with 77 amoxicillin-susceptible strains. Helicobacter 2017;22. [PMID: 28840971 DOI: 10.1111/hel.12437] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 137 |
Macías-García F, Llovo-Taboada J, Díaz-López M, Bastón-Rey I, Domínguez-Muñoz JE. High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: A prevalence cross-sectional study in Spain. Helicobacter 2017;22. [PMID: 28913872 DOI: 10.1111/hel.12440] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 138 |
Abadi ATB. Resistance to clarithromycin and gastroenterologist’s persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization. World J Gastroenterol 2017; 23(35): 6379-6384 [PMID: 29085187 DOI: 10.3748/wjg.v23.i35.6379] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 139 |
Shiota S, Thrift AP, Green L, Shah R, Verstovsek G, Rugge M, Graham DY, El-Serag HB. Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol 2017;15:1037-1046.e3. [PMID: 28110098 DOI: 10.1016/j.cgh.2017.01.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 140 |
Abu-Sini M, Mayyas A, Al-Karablieh N, Darwish R, Al-Hiari Y, Aburjai T, Arabiyat S, Abu-Qatouseh L. Synthesis of 1,2,3-Triazolo[4,5-h]quinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant Helicobacter pylori. Molecules 2017;22:E841. [PMID: 28531095 DOI: 10.3390/molecules22050841] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 141 |
Smith S, Boyle B, Brennan D, Buckley M, Crotty P, Doyle M, Farrell R, Hussey M, Kevans D, Malfertheiner P, Megraud F, Nugent S, O'Connor A, O'Morain C, Weston S, McNamara D. The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland. Eur J Gastroenterol Hepatol 2017;29:552-9. [PMID: 28350745 DOI: 10.1097/MEG.0000000000000822] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 142 |
Arslan N, Yılmaz Ö, Demiray-Gürbüz E. Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection. World J Gastroenterol 2017; 23(16): 2854-2869 [PMID: 28522904 DOI: 10.3748/wjg.v23.i16.2854] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 143 |
Navarro-Jarabo JM, Fernández-Sánchez F, Fernández-Moreno N, Hervas-Molina AJ, Casado-Caballero F, Puente-Gutierrez JJ, Pallares-Manrique H, Rodríguez-Ramos C, Fernández-Gutierrez C, Pérez-Aisa A, Rivas-Ruiz F, Montiel Quezel-Guerraz N. Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain. Digestion 2015;92:78-82. [PMID: 26227669 DOI: 10.1159/000435949] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 144 |
Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kim HK, Lee YD. Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes. World J Gastroenterol 2017; 23(6): 1059-1066 [PMID: 28246480 DOI: 10.3748/wjg.v23.i6.1059] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 145 |
Figueiredo C. Helicobacter pylori Infection. Encyclopedia of Pathology 2017. [DOI: 10.1007/978-3-319-40560-5_1631] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 146 |
Mosińska P, Sałaga M. Diagnostic Criteria in Peptic Ulcer Disease. Introduction to Gastrointestinal Diseases Vol. 2 2017. [DOI: 10.1007/978-3-319-59885-7_4] [Reference Citation Analysis]
|
| 147 |
Enroth H, Engstrand L. Helicobacter pylori. International Encyclopedia of Public Health 2017. [DOI: 10.1016/b978-0-12-803678-5.00200-9] [Reference Citation Analysis]
|
| 148 |
Mégraud F, Musso D, Drancourt M, Lehours P. Curved and Spiral Bacilli. Infectious Diseases 2017. [DOI: 10.1016/b978-0-7020-6285-8.00182-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 149 |
Shetty V, Ballal M, Balaraju G, Shetty S, Pai GC, Lingadakai R. Helicobacter pylori in Dyspepsia: Phenotypic and Genotypic Methods of Diagnosis. J Glob Infect Dis 2017;9:131-4. [PMID: 29302146 DOI: 10.4103/jgid.jgid_52_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 150 |
Mcdermott PF, Mégraud F. Antimicrobial Resistance in Helicobacter and Campylobacter. Antimicrobial Drug Resistance 2017. [DOI: 10.1007/978-3-319-47266-9_14] [Reference Citation Analysis]
|
| 151 |
Enroth H. OBSOLETE: Infectious Diseases: Helicobacter pylori. Reference Module in Biomedical Sciences 2017. [DOI: 10.1016/b978-0-12-801238-3.98785-3] [Reference Citation Analysis]
|
| 152 |
Basiri Z, Safaralizadeh R, Jabbarpour Bonyadi M, Abdolmohammadi R, Somi MH. Identification of Gastric Cancer-Related Strains of Helicobacter pylori: Findings from Single Biopsy Specimens for PCR and Campylobacter-Like Organism Test. Jundishapur J Microbiol 2016;10. [DOI: 10.5812/jjm.37006] [Reference Citation Analysis]
|
| 153 |
Peña J, Rojas H, Reyes N, Fernández-Delgado M, García-Amado MA, Michelangeli F, Contreras M. Multiple cag genotypes of Helicobacter pylori isolates colonize the oesophagus in individual hosts in a Venezuelan population. J Med Microbiol 2017;66:226-35. [PMID: 27983473 DOI: 10.1099/jmm.0.000409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 154 |
Hanafi A, Lee WC, Loke MF, Teh X, Shaari A, Dinarvand M, Lehours P, Mégraud F, Leow AH, Vadivelu J, Goh KL. Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori. Front Microbiol 2016;7:2015. [PMID: 28018334 DOI: 10.3389/fmicb.2016.02015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 155 |
Demiray-Gürbüz E, Yılmaz Ö, Olivares AZ, Gönen C, Sarıoğlu S, Soytürk M, Tümer S, Altungöz O, Şimşek İ, Perez Perez GI. Rapid identification of Helicobacter pylori and assessment of clarithromycin susceptibility from clinical specimens using FISH. J Pathol Clin Res 2017;3:29-37. [PMID: 28138399 DOI: 10.1002/cjp2.57] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 156 |
Liou JM, Chen CC, Chang CY, Chen MJ, Chen CC, Fang YJ, Lee JY, Yang TH, Luo JC, Wu JY, Liou TC, Chang WH, Hsu YC, Tseng CH, Chang CC, Bair MJ, Liu TY, Hsieh CF, Tsao FY, Shun CT, Lin JT, Lee YC, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial. Gut 2016;65:1784-92. [PMID: 26338825 DOI: 10.1136/gutjnl-2015-310142] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 157 |
Fujiya Y, Nagamatsu M, Tomida J, Kawamura Y, Yamamoto K, Mawatari M, Kutsuna S, Takeshita N, Hayakawa K, Kanagawa S, Mezaki K, Hashimoto M, Ishii S, Ohmagari N. Successful treatment of recurrent Helicobacter fennelliae bacteraemia by selective digestive decontamination with kanamycin in a lung cancer patient receiving chemotherapy. JMM Case Rep 2016;3:e005069. [PMID: 28348791 DOI: 10.1099/jmmcr.0.005069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 158 |
Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, Wu JY, Kuo CH, Huang YK, Wu DC. Diagnosis of Helicobacter pylori infection: Current options and developments. World J Gastroenterol. 2015;21:11221-11235. [PMID: 26523098 DOI: 10.3748/wjg.v21.i40.11221.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 159 |
Sanches BS, Martins GM, Lima K, Cota B, Moretzsohn LD, Ribeiro LT, Breyer HP, Maguilnik I, Maia AB, Rezende-Filho J, Meira AC, Pinto H, Alves E, Mascarenhas R, Passos R, de Souza JD, Trindade OR, Coelho LG. Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. World J Gastroenterol 2016; 22(33): 7587-7594 [PMID: 27672279 DOI: 10.3748/wjg.v22.i33.7587] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 160 |
Ang TL, Fock KM, Ang D, Kwek AB, Teo EK, Dhamodaran S. The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15-Year Study. Helicobacter 2016;21:261-5. [PMID: 26774006 DOI: 10.1111/hel.12291] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 161 |
Nyssen OP, McNicholl AG, Megraud F, Savarino V, Oderda G, Fallone CA, Fischbach L, Bazzoli F, Gisbert JP. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication. Cochrane Database Syst Rev 2016;:CD009034. [PMID: 27351542 DOI: 10.1002/14651858.CD009034.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 162 |
Shmuely H, Domniz N, Yahav J. Non-pharmacological treatment of Helicobacter pylori. World J Gastrointest Pharmacol Ther 2016; 7(2): 171-178 [PMID: 27158532 DOI: 10.4292/wjgpt.v7.i2.171] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 163 |
Dore MP, Pes GM, Bassotti G, Usai-Satta P. Dyspepsia: When and How to Test for Helicobacter pylori Infection. Gastroenterol Res Pract 2016;2016:8463614. [PMID: 27239194 DOI: 10.1155/2016/8463614] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 164 |
Quek C, Pham ST, Tran KT, Pham BT, Huynh LV, Luu NB, Le TK, Quek K, Pham VH. Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam. F1000Res 2016;5:671. [PMID: 27583131 DOI: 10.12688/f1000research.8239.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 165 |
Hassan TMM, Al-Najjar SI, Al-Zahrani IH, Alanazi FIB, Alotibi MG. Helicobacter pylori chronic gastritis updated Sydney grading in relation to endoscopic findings and H. pylori IgG antibody: diagnostic methods. J Microsc Ultrastruct 2016;4:167-74. [PMID: 30023224 DOI: 10.1016/j.jmau.2016.03.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 166 |
Talebi Bezmin Abadi A. Vaccine against Helicobacter pylori: Inevitable approach. World J Gastroenterol 2016; 22(11): 3150-3157 [PMID: 27003991 DOI: 10.3748/wjg.v22.i11.3150] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 167 |
Lee ST, Lee DH, Lim JH, Kim N, Park YS, Shin CM, Jo HJ, Song IS. Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection. Gut Liver. 2015;9:478-485. [PMID: 25071068 DOI: 10.5009/gnl14020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 168 |
Di Giulio M, Di Campli E, Di Bartolomeo S, Cataldi V, Marzio L, Grossi L, Ciccaglione AF, Nostro A, Cellini L. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. Scand J Gastroenterol 2016;51:263-9. [PMID: 26554617 DOI: 10.3109/00365521.2015.1092577] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 169 |
Korkut Y, Kilit T, Işık İ, Kilit C. Dispepsi Şikâyeti ile Başvuran Hastalarda Helikobakter Pilori Pozitifliği Açısından C-14 Üre Nefes Testi ile Endoskopinin Karşılaştırılması. Aile Hekimliği ve Palyatif Bakım 2016;1:9-9. [DOI: 10.22391/920.182937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 170 |
Vilaichone RK, Ratanachu-Ek T, Gamnarai P, Chaithongrat S, Uchida T, Yamaoka Y, Mahachai V. Extremely High Prevalence of Metronidazole-Resistant Helicobacter pylori Strains in Mountain People (Karen and Hmong) in Thailand. Am J Trop Med Hyg 2016;94:717-20. [PMID: 26880772 DOI: 10.4269/ajtmh.15-0449] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 171 |
Szkaradkiewicz A, Karpiński TM, Linke K, Majewski P, Rożkiewicz D, Goślińska-Kuźniarek O. Expression of cagA, virB/D Complex and/or vacA Genes in Helicobacter pylori Strains Originating from Patients with Gastric Diseases. PLoS One 2016;11:e0148936. [PMID: 26866365 DOI: 10.1371/journal.pone.0148936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 172 |
Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther 2016;43:514-33. [PMID: 26694080 DOI: 10.1111/apt.13497] [Cited by in Crossref: 410] [Cited by in F6Publishing: 381] [Article Influence: 58.6] [Reference Citation Analysis]
|
| 173 |
Calik Z, Karamese M, Acar O, Aksak Karamese S, Dicle Y, Albayrak F, Can S, Guvendi B, Turgut A, Cicek M. Investigation of Helicobacter pylori antigen in stool samples of patients with upper gastrointestinal complaints. Braz J Microbiol. 2016;47:167-171. [PMID: 26887240 DOI: 10.1016/j.bjm.2015.11.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 174 |
Dunn BE, Phadnis SH. Diagnosis of Helicobacter pylori Infection and Assessment of Eradication. Manual of Molecular and Clinical Laboratory Immunology 2016. [DOI: 10.1128/9781555818722.ch45] [Reference Citation Analysis]
|
| 175 |
Jia K, An L, Wang F, Shi L, Ran X, Wang X, He Z, Chen J. Aggravation of Helicobacter pylori stomach infections in stressed military recruits. J Int Med Res 2016;44:367-76. [PMID: 26800706 DOI: 10.1177/0300060515593768] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 176 |
Miftahussurur M, Yamaoka Y. Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int 2016;2016:4819423. [PMID: 26904678 DOI: 10.1155/2016/4819423] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 177 |
Perrone S, D'Elia GM, Annechini G, Pulsoni A. Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy. Mediterr J Hematol Infect Dis 2016;8:e2016006. [PMID: 26740867 DOI: 10.4084/MJHID.2016.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 178 |
Li J, Li X. Antimicrobial Resistance and Drug Efflux Pumps in Helicobacter. Efflux-Mediated Antimicrobial Resistance in Bacteria 2016. [DOI: 10.1007/978-3-319-39658-3_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 179 |
Miftahussurur M, Yamaoka Y. Population-Based Strategies for Helicobacter pylori-Associated Disease Management: Asian Perspective. Helicobacter pylori Research 2016. [DOI: 10.1007/978-4-431-55936-8_23] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 180 |
Kwon YH. Tailored Therapy Based on Antibiotic Resistance. Helicobacter pylori 2016. [DOI: 10.1007/978-981-287-706-2_45] [Reference Citation Analysis]
|
| 181 |
Burd EM, Hinrichs BH. Gastrointestinal Infections. Molecular Pathology in Clinical Practice 2016. [DOI: 10.1007/978-3-319-19674-9_50] [Reference Citation Analysis]
|
| 182 |
Kim J. Culture. Helicobacter pylori 2016. [DOI: 10.1007/978-981-287-706-2_10] [Reference Citation Analysis]
|
| 183 |
Smith SM. An Update on the Treatment of Helicobacter Pylori Infection. EMJ Gastroenterol 2015. [DOI: 10.33590/emjgastroenterol/10310813] [Reference Citation Analysis]
|
| 184 |
Ingram RJ, Ragunath K, Atherton JC. Peptic Ulcer Disease. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch56] [Reference Citation Analysis]
|
| 185 |
Sokic-Milutinovic A, Alempijevic T, Milosavljevic T. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. World J Gastroenterol 2015; 21(41): 11654-11672 [PMID: 26556993 DOI: 10.3748/wjg.v21.i41.11654] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 186 |
Kim SE, Park MI, Park SJ, Moon W, Choi YJ, Cheon JH, Kwon HJ, Ku KH, Yoo CH, Kim JH. Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy. Korean J Intern Med. 2015;30:801-807. [PMID: 26552455 DOI: 10.3904/kjim.2015.30.6.801] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 187 |
Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, Wu JY, Kuo CH, Huang YK, Wu DC. Diagnosis of Helicobacter pylori infection: Current options and developments. World J Gastroenterol 2015; 21(40): 11221-11235 [PMID: 26523098 DOI: 10.3748/wjg.v21.i40.11221] [Cited by in CrossRef: 193] [Cited by in F6Publishing: 211] [Article Influence: 24.1] [Reference Citation Analysis]
|
| 188 |
Enany S, Abdalla S. In vitro antagonistic activity of Lactobacillus casei against Helicobacter pylori. Braz J Microbiol 2015;46:1201-6. [PMID: 26691482 DOI: 10.1590/S1517-838246420140675] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 189 |
Wu IT, Chuah SK, Lee CH, Liang CM, Lu LS, Kuo YH, Yen YH, Hu ML, Chou YP, Yang SC, Kuo CM, Kuo CH, Chien CC, Chiang YS, Chiou SS, Hu TH, Tai WC. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. World J Gastroenterol 2015; 21(37): 10669-10674 [PMID: 26457027 DOI: 10.3748/wjg.v21.i37.10669] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 190 |
Ciccaglione AF, Cellini L, Grossi L, Manzoli L, Marzio L. A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study. Helicobacter 2015;20:390-6. [PMID: 25801708 DOI: 10.1111/hel.12209] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 191 |
Uchida T, Miftahussurur M, Pittayanon R, Vilaichone RK, Wisedopas N, Ratanachu-Ek T, Kishida T, Moriyama M, Yamaoka Y, Mahachai V. Helicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype. PLoS One. 2015;10:e0136775. [PMID: 26355839 DOI: 10.1371/journal.pone.0136775] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 192 |
Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clin Gastroenterol Hepatol 2015;13:1616-24. [PMID: 25681693 DOI: 10.1016/j.cgh.2015.02.005] [Cited by in Crossref: 114] [Cited by in F6Publishing: 115] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 193 |
John A, Al Kaabi S, Doiphode S, Chandra P, Sharma M, Babu R, Yacoub R, Derbala M. Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection? Indian J Gastroenterol 2015;34:404-7. [PMID: 26541342 DOI: 10.1007/s12664-015-0604-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 194 |
Zulfiqar A, Martin-kleisch A, Andres E, Novella J. Carence en vitamine B12 chez le sujet âgé : bien penser à rechercher une infection à Helicobacter pylori. Nutrition Clinique et Métabolisme 2015;29:163-165. [DOI: 10.1016/j.nupar.2015.05.003] [Reference Citation Analysis]
|
| 195 |
Eng NF, Ybazeta G, Chapman K, Fraleigh NL, Letto R, Altman E, Diaz-Mitoma F. Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario. Can J Infect Dis Med Microbiol 2015;26:137-44. [PMID: 26236355 DOI: 10.1155/2015/853287] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 196 |
Ontsira Ngoyi EN, Atipo Ibara BI, Moyen R, Ahoui Apendi PC, Ibara JR, Obengui O, Ossibi Ibara RB, Nguimbi E, Niama RF, Ouamba JM, Yala F, Abena AA, Vadivelu J, Goh KL, Menard A, Benejat L, Sifre E, Lehours P, Megraud F. Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo. Helicobacter 2015;20:316-20. [PMID: 25585658 DOI: 10.1111/hel.12204] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 197 |
Liu J, He L, Haesebrouck F, Gong Y, Flahou B, Cao Q, Zhang J. Prevalence of Coinfection with Gastric Non-Helicobacter pylori Helicobacter (NHPH) Species in Helicobacter pylori-infected Patients Suffering from Gastric Disease in Beijing, China. Helicobacter 2015;20:284-90. [PMID: 25510739 DOI: 10.1111/hel.12201] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 198 |
Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication. World J Gastroenterol 2015; 21(26): 8132-8139 [PMID: 26185386 DOI: 10.3748/wjg.v21.i26.8132] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 199 |
Liu XF, Cheng GX, Yuan YP, Zhang AM, Luo J, Liu SG, Chen JQ, Dong XQ, Zhang L, Ma LQ. Effect of recombinant human lactoferrin treatment on mRNA expression of vacuolating cytotoxin A and content of tumor necrosis factor-α in gastric tissue of mice with Helicobacter pylori-associated gastritis. Shijie Huaren Xiaohua Zazhi 2015; 23(18): 2860-2867 [DOI: 10.11569/wcjd.v23.i18.2860] [Reference Citation Analysis]
|
| 200 |
McMahon BJ, Bruce MG, Koch A, Goodman KJ, Tsukanov V, Mulvad G, Borresen ML, Sacco F, Barrett D, Westby S, Parkinson AJ. The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary. Epidemiol Infect 2016;144:225-33. [PMID: 26094936 DOI: 10.1017/S0950268815001181] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 201 |
Vellozzi E, Giugliano E. The Genus Helicobacter. Practical Handbook of Microbiology, Third Edition 2015. [DOI: 10.1201/b17871-42] [Reference Citation Analysis]
|
| 202 |
Powers-fletcher MV, Couturier MR. Non-Helicobacter pylori Helicobacter Species Associated with Human Disease: a Primer for the Clinical Microbiology Laboratory. Clinical Microbiology Newsletter 2015;37:93-101. [DOI: 10.1016/j.clinmicnews.2015.05.004] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 203 |
Lawson AJ. Helicobacter. Manual of
Clinical Microbiology 2015. [DOI: 10.1128/9781555817381.ch57] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 204 |
Yang JC, Lin CJ, Wang HL, Chen JD, Kao JY, Shun CT, Lu CW, Lin BR, Shieh MJ, Chang MC, Chang YT, Wei SC, Lin LC, Yeh WC, Kuo JS, Tung CC, Leong YL, Wang TH, Wong JM. High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection. Clin Gastroenterol Hepatol 2015;13:895-905.e5. [PMID: 25460556 DOI: 10.1016/j.cgh.2014.10.036] [Cited by in Crossref: 114] [Cited by in F6Publishing: 123] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 205 |
Miftahussurur M, Yamaoka Y. Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Molecules. 2015;20:6068-6092. [PMID: 25856059 DOI: 10.3390/molecules20046068] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 206 |
Wang F, Zhu L, Xiong Y, Qi TN, Jiang Y, Chen ZH. Antibiotic resistance of Helicobacter pylori clinical isolates from children in Guiyang area. Shijie Huaren Xiaohua Zazhi 2015; 23(8): 1369-1373 [DOI: 10.11569/wcjd.v23.i8.1369] [Reference Citation Analysis]
|
| 207 |
Zhang YX, Zhou LY, Song ZQ, Zhang JZ, He LH, Ding Y. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study. World J Gastroenterol 2015; 21(9): 2786-2792 [PMID: 25759550 DOI: 10.3748/wjg.v21.i9.2786] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 208 |
Ogata SK, Gales AC, Kawakami E. Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion. Braz J Microbiol 2014;45:1439-48. [PMID: 25763052 DOI: 10.1590/s1517-83822014000400039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 209 |
Chen ZL, Lv YH, Wang D, Tu X. In vitro bacteriostatic activity of Qingre Huashi Shuwei formula and its hot-cold drug combinations against Helicobacter pylori. Shijie Huaren Xiaohua Zazhi 2015; 23(6): 949-953 [DOI: 10.11569/wcjd.v23.i6.949] [Reference Citation Analysis]
|
| 210 |
Yoon H, Lee DH, Jang ES, Kim J, Shin CM, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N. Optimal initiation of Helicobacter pylori eradication in patients with peptic ulcer bleeding. World J Gastroenterol 2015; 21(8): 2497-2503 [PMID: 25741160 DOI: 10.3748/wjg.v21.i8.2497] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 211 |
Nijevitch AA, Idrisov B, Akhmadeeva EN, Graham DY. Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance. Curr Pharm Des 2014;20:4510-6. [PMID: 24180406 DOI: 10.2174/13816128113196660728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 212 |
Binh TT, Suzuki R, Trang TT, Kwon DH, Yamaoka Y. Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. Antimicrob Agents Chemother. 2015;59:2343-2348. [PMID: 25645832 DOI: 10.1128/aac.04852-14] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 213 |
Verma M. Multiple Infections and Cancer: Etiology, Mechanisms and Implications in Cancer Control. Infection and Cancer: Bi-Directorial Interactions 2015. [DOI: 10.1007/978-3-319-20669-1_8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 214 |
Al-Moayad EE, Alghalibi SM, Al-Shamahy HA, Nasher AT, Al-Hebshi NN. Normalized real-time PCR for diagnosis of H. pylori infection. Qatar Med J. 2014;2014:123-129. [PMID: 25745602 DOI: 10.5339/qmj.2014.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 215 |
Song Z, Zhang J, He L, Chen M, Hou X, Li Z, Zhou L. Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients. Dig Liver Dis 2014;46:1077-81. [PMID: 25220697 DOI: 10.1016/j.dld.2014.08.038] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 216 |
Selgrad M, Tammer I, Langner C, Bornschein J, Meißle J, Kandulski A, Varbanova M, Wex T, Schlüter D, Malfertheiner P. Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection. World J Gastroenterol 2014; 20(43): 16245-16251 [PMID: 25473179 DOI: 10.3748/wjg.v20.i43.16245] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 217 |
Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of Helicobacter pylori infection: Past, present and future. World J Gastrointest Pathophysiol 2014; 5(4): 392-399 [PMID: 25400982 DOI: 10.4291/wjgp.v5.i4.392] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 218 |
Bezmin Abadi AT. A Rare Case of Helicobacter pylori Mix Infections and Recurrence of Duodenal Ulcers. MOJCR 2014;1. [DOI: 10.15406/mojcr.2014.01.00001] [Reference Citation Analysis]
|
| 219 |
Marín AC, Mcnicholl AG, Savarino V, Calvet X, Leontiadis GI, Fischbach L, Yuan Y, Gisbert JP; Cochrane Upper GI and Pancreatic Diseases Group. Optimum second-line regimens for Helicobacter pylori eradication. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd011363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 220 |
Cellini L, Di Campli E, Di Bartolomeo S, Bessa LJ, Baffoni M, Di Giulio M. New transport medium for cultural recovery of Helicobacter pylori. J Clin Microbiol. 2014;52:4325-4329. [PMID: 25320229 DOI: 10.1128/jcm.02850-14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 221 |
Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of Helicobacter pylori: What should be the gold standard? World J Gastroenterol 2014; 20(36): 12847-12859 [PMID: 25278682 DOI: 10.3748/wjg.v20.i36.12847] [Cited by in CrossRef: 140] [Cited by in F6Publishing: 153] [Article Influence: 15.6] [Reference Citation Analysis]
|
| 222 |
Lee JW, Kim N, Nam RH, Park JH, Choi YJ, Kim JM, Kim JS, Jung HC. GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. Scand J Gastroenterol 2014;49:1058-67. [PMID: 24957849 DOI: 10.3109/00365521.2014.894117] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 223 |
Chuah SK, Tai WC, Lee CH, Liang CM, Hu TH. Quinolone-containing therapies in the eradication of Helicobacter pylori. Biomed Res Int. 2014;2014:151543. [PMID: 25243116 DOI: 10.1155/2014/151543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 224 |
Smith SM, O’Morain C, McNamara D. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol 2014; 20(29): 9912-9921 [PMID: 25110421 DOI: 10.3748/wjg.v20.i29.9912] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 96] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 225 |
Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of Helicobacter pylori infection: Meeting the challenge of antimicrobial resistance. World J Gastroenterol 2014; 20(29): 9898-9911 [PMID: 25110420 DOI: 10.3748/wjg.v20.i29.9898] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 74] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 226 |
Yue JY, Yue J, Wang MY, Song WC, Gao XZ. CagA status & genetic characterization of metronidazole resistant strains of H. pylori from: A region at high risk of gastric cancer. Pak J Med Sci 2014;30:804-8. [PMID: 25097521 DOI: 10.12669/pjms.304.4840] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 227 |
Yılmaz T, Bajin MD, Günaydın R&, Özer S, Sözen T. Laryngopharyngeal reflux and Helicobacter pylori. World J Gastroenterol 2014; 20(27): 8964-8970 [PMID: 25083069 DOI: 10.3748/wjg.v20.i27.8964] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 228 |
Shiota S, Cruz M, Abreu JAJ, Mitsui T, Terao H, Disla M, Iwatani S, Nagashima H, Matsuda M, Uchida T, Tronilo L, Rodríguez E, Yamaoka Y. Virulence genes of Helicobacter pylori in the Dominican Republic. J Med Microbiol 2014;63:1189-96. [PMID: 24965801 DOI: 10.1099/jmm.0.075275-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 229 |
Chung WC, Jung SH, Oh JH, Kim TH, Cheung DY, Kim BW, Kim SS, Kim JI, Sin EY. Dual-priming oligonucleotide-based multiplex PCR using tissue samples in rapid urease test in the detection of Helicobacter pylori infection. World J Gastroenterol 2014; 20(21): 6547-6553 [PMID: 24914376 DOI: 10.3748/wjg.v20.i21.6547] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 230 |
Cammarota G, Ianiro G, Bibbò S, Di Rienzo TA, Masucci L, Sanguinetti M, Gasbarrini A. Culture-guided treatment approach for Helicobacter pylori infection: Review of the literature. World J Gastroenterol 2014; 20(18): 5205-5211 [PMID: 24833850 DOI: 10.3748/wjg.v20.i18.5205] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 231 |
Fu HW. Helicobacter pylori neutrophil-activating protein: From molecular pathogenesis to clinical applications. World J Gastroenterol 2014; 20(18): 5294-5301 [PMID: 24833859 DOI: 10.3748/wjg.v20.i18.5294] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 232 |
Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: Current status and future concepts. World J Gastroenterol 2014; 20(18): 5283-5293 [PMID: 24833858 DOI: 10.3748/wjg.v20.i18.5283] [Cited by in CrossRef: 110] [Cited by in F6Publishing: 117] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 233 |
Lee HK, Song HE, Lee HB, Kim CS, Koketsu M, Ngan LT, Ahn YJ. Growth inhibitory, bactericidal, and morphostructural effects of dehydrocostus lactone from Magnolia sieboldii Leaves on antibiotic-susceptible and -resistant strains of Helicobacter pylori. PLoS One 2014;9:e95530. [PMID: 24747984 DOI: 10.1371/journal.pone.0095530] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 234 |
Camargo MC, García A, Riquelme A, Otero W, Camargo CA, Hernandez-García T, Candia R, Bruce MG, Rabkin CS. The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am J Gastroenterol 2014;109:485-95. [PMID: 24589670 DOI: 10.1038/ajg.2014.24] [Cited by in Crossref: 111] [Cited by in F6Publishing: 119] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 235 |
Talebi Bezmin Abadi A. Therapy of Helicobacter pylori: present medley and future prospective. Biomed Res Int. 2014;2014:124607. [PMID: 24800203 DOI: 10.1155/2014/124607] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 236 |
Almeida N, Romãozinho JM, Donato MM, Luxo C, Cardoso O, Cipriano MA, Marinho C, Sofia C. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study. Helicobacter 2014;19:90-7. [PMID: 24506175 DOI: 10.1111/hel.12106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 237 |
Binh TT, Shiota S, Suzuki R, Matsuda M, Trang TT, Kwon DH, Iwatani S, Yamaoka Y. Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing. J Antimicrob Chemother. 2014;69:1796-1803. [PMID: 24648504 DOI: 10.1093/jac/dku050] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 238 |
Yee KC, Wei MH, Yee HC, Everett KD, Yee HP, Hazeki-Talor N. A screening trial of Helicobacter pylori-specific antigen tests in saliva to identify an oral infection. Digestion 2013;87:163-9. [PMID: 23615458 DOI: 10.1159/000350432] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 239 |
Talebi Bezmin Abadi A, Mohabbati Mobarez A. High Prevalence of Helicobacter pylori hopQ II Genotype Isolated from Iranian Patients with Gastroduodenal Disorders. J Pathog. 2014;2014:842469. [PMID: 24672729 DOI: 10.1155/2014/842469] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 240 |
Mirzaei T, Alebouyeh M, Shokrzadeh L, Asadzadeh Aghdaei H, Farzi N, Zojaji H, Zali MR. Smoking, Proton Pump Inhibitors and Antibiotic Administration as Factors Affecting Direct Screening of Helicobacter Pylori Infection Among Patients With Dyspepsia. Arch Clin Infect Dis 2014;9. [DOI: 10.5812/archcid.15774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 241 |
Kraus J, Nártová E, Pavlík E, Katra R, Sterzl I, Astl J. Prevalence of Helicobacter pylori in adenotonsillar hypertrophy in children. Acta Otolaryngol 2014;134:88-92. [PMID: 24256044 DOI: 10.3109/00016489.2013.840924] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 242 |
Emara MH, Mohamed SY, Abdel-Aziz HR. Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial. Therap Adv Gastroenterol 2014;7:4-13. [PMID: 24381643 DOI: 10.1177/1756283X13503514] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 243 |
Carneiro F. Gastric Cancer. Pathobiology of Human Disease 2014. [DOI: 10.1016/b978-0-12-386456-7.03808-9] [Reference Citation Analysis]
|
| 244 |
Ierardi E, Giorgio F, Losurdo G, Di Leo A, Principi M. How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography? World J Gastroenterol 2013; 19(45): 8168-8180 [PMID: 24363506 DOI: 10.3748/wjg.v19.i45.8168] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 80] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 245 |
Suzuki RB, Lopes RA, da Câmara Lopes GA, Hung Ho T, Sperança MA. Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil. BMC Gastroenterol 2013;13:164. [PMID: 24305035 DOI: 10.1186/1471-230X-13-164] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 246 |
Khalifehgholi M, Shamsipour F, Ajhdarkosh H, Ebrahimi Daryani N, Pourmand MR, Hosseini M, Ghasemi A, Shirazi MH. Comparison of five diagnostic methods for Helicobacter pylori. Iran J Microbiol 2013;5:396-401. [PMID: 25848511] [Reference Citation Analysis]
|
| 247 |
Selgrad M, Meissle J, Bornschein J, Kandulski A, Langner C, Varbanova M, Wex T, Tammer I, Schlüter D, Malfertheiner P. Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies. Eur J Gastroenterol Hepatol 2013;25:1257-60. [PMID: 23863261 DOI: 10.1097/MEG.0b013e3283643491] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 248 |
Mégraud F. Current recommendations for Helicobacter pylori therapies in a world of evolving resistance. Gut Microbes 2013;4:541-8. [PMID: 23929066 DOI: 10.4161/gmic.25930] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 249 |
Farjadi V, Abtahi H, Zolfaghari MR, Soufian S, Hasanzadeh L. Expression, Purification and Evaluation of Antigenicity of CagA Antigenic Fragment of Helicobacter pylori. Jundishapur J Microbiol 2013;6. [DOI: 10.5812/jjm.7367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 250 |
Vilaichone RK, Yamaoka Y, Shiota S, Ratanachu-ek T, Tshering L, Uchida T, Fujioka T, Mahachai V. Antibiotics resistance rate of Helicobacter pylori in Bhutan. World J Gastroenterol 2013; 19(33): 5508-5512 [PMID: 24023494 DOI: 10.3748/wjg.v19.i33.5508] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 251 |
Altman E, Chandan V, Harrison B. The potential of dextran-based glycoconjugates for development of Helicobacter pylori vaccine. Glycoconj J. 2014;31:13-24. [PMID: 23990317 DOI: 10.1007/s10719-013-9496-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 252 |
Biernat MM, Poniewierka E, Błaszczuk J, Czapla L, Kempiński R, Ksiądzyna D, Grabińska J, Bińkowska A, Megraud F, Gościniak G. Antimicrobial susceptibility of Helicobacter pylori isolates from Lower Silesia, Poland. Arch Med Sci 2014;10:505-9. [PMID: 25097581 DOI: 10.5114/aoms.2013.36917] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 253 |
Aziz F, Sherwani SK, Akhtar SS, Kazmi SU. Development of an in-house enzyme-linked immunosorbent assay based on surface whole cell antigen for diagnosis of Helicobacter pylori infection in patients with gastroduodenal ulcer disease. World J Microbiol Biotechnol. 2014;30:305-315. [PMID: 23921679 DOI: 10.1007/s11274-013-1448-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 254 |
Su P, Li Y, Li H, Zhang J, Lin L, Wang Q, Guo F, Ji Z, Mao J, Tang W, Shi Z, Shao W, Mao J, Zhu X, Zhang X, Tong Y, Tu H, Jiang M, Wang Z, Jin F, Yang N, Zhang J. Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China. Helicobacter 2013;18:274-9. [PMID: 23418857 DOI: 10.1111/hel.12046] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 255 |
Xiang Z, Chen YP, Ye YF, Ma KF, Chen SH, Zheng L, Yang YD, Jin X. Helicobacter pylori and Crohn’s disease: A retrospective single-center study from China. World J Gastroenterol 2013; 19(28): 4576-4581 [PMID: 23901235 DOI: 10.3748/wjg.v19.i28.4576] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 256 |
Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57:e22-e121. [PMID: 23845951 DOI: 10.1093/cid/cit278] [Cited by in Crossref: 327] [Cited by in F6Publishing: 338] [Article Influence: 32.7] [Reference Citation Analysis]
|
| 257 |
Ogata SK, Godoy AP, da Silva Patricio FR, Kawakami E. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents. J Pediatr Gastroenterol Nutr 2013;56:645-8. [PMID: 23403439 DOI: 10.1097/MPG.0b013e31828b3669] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 258 |
Lee JW, Kim N, Kim JM, Nam RH, Chang H, Kim JY, Shin CM, Park YS, Lee DH, Jung HC. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 2013;18:206-14. [PMID: 23241101 DOI: 10.1111/hel.12031] [Cited by in Crossref: 181] [Cited by in F6Publishing: 176] [Article Influence: 18.1] [Reference Citation Analysis]
|
| 259 |
Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, Mégraud F, Zerbib F, Raymond J, Fauchère JL. Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter 2013;18:169-79. [PMID: 23316886 DOI: 10.1111/hel.12030] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 260 |
Saracino IM, Zaccaro C, Re GL, Vaira D, Holton J. The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori. Antibiotics (Basel) 2013;2:265-73. [PMID: 27029303 DOI: 10.3390/antibiotics2020265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 261 |
Vilaichone RK, Mahachai V, Shiota S, Uchida T, Ratanachu-ek T, Tshering L, Tung NL, Fujioka T, Moriyama M, Yamaoka Y. Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol 2013; 19(18): 2806-2810 [PMID: 23687418 DOI: 10.3748/wjg.v19.i18.2806] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 262 |
Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD, Zhou LY, Chen Y, Zeng ZR, Wang CW, Xiao SD, Pan GZ, Hu PJ; Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 2013;14:211-21. [PMID: 23302262 DOI: 10.1111/1751-2980.12034] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 263 |
Blondeau J, Chan CK, Davidson R. Judicious use of antibiotics to minimize emerging resistance: the macrolide clarithromycin as a case study. Clinical Practice 2013;10:359-370. [DOI: 10.2217/cpr.13.21] [Reference Citation Analysis]
|
| 264 |
Abadi AT, Bonten MJ, Kusters JG. Comment to: "Different Antibiotic No Culture Eradication (DANCE) of Helicobacter pylori: an easy way to manage H. pylori eradication". Dig Liver Dis 2013;45:438. [PMID: 23369689 DOI: 10.1016/j.dld.2012.12.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 265 |
Cerqueira L, Fernandes RM, Ferreira RM, Oleastro M, Carneiro F, Brandão C, Pimentel-Nunes P, Dinis-Ribeiro M, Figueiredo C, Keevil CW, Vieira MJ, Azevedo NF. Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol 2013;51:1887-93. [PMID: 23596234 DOI: 10.1128/JCM.00302-13] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 266 |
Essawi T, Hammoudeh W, Sabri I, Sweidan W, Farraj MA. Determination of Helicobacter pylori Virulence Genes in Gastric Biopsies by PCR. ISRN Gastroenterol. 2013;2013:606258. [PMID: 23691338 DOI: 10.1155/2013/606258] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 267 |
Boyanova L, Ilieva J, Gergova G, Evstatiev I, Nikolov R, Mitov I. Living in Sofia is associated with a risk for antibiotic resistance in Helicobacter pylori: a Bulgarian study. Folia Microbiol (Praha). 2013;58:587-591. [PMID: 23580173 DOI: 10.1007/s12223-013-0251-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 268 |
Binh TT, Shiota S, Nguyen LT, Ho DD, Hoang HH, Ta L, Trinh DT, Fujioka T, Yamaoka Y. The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam. J Clin Gastroenterol 2013;47:233-8. [PMID: 23090037 DOI: 10.1097/MCG.0b013e3182676e2b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 269 |
Islam A, Oguz H, Yucel M, Koca G, Gonultas MA, Arslan N, Demirci M. Does Helicobacter pylori Exist in Vocal Fold Pathologies and in the Interarytenoid Region? Dysphagia 2013;28:382-7. [DOI: 10.1007/s00455-012-9444-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 270 |
Holton J. Peptic Ulcer Disease. Genomic and Personalized Medicine 2013. [DOI: 10.1016/b978-0-12-382227-7.00077-x] [Reference Citation Analysis]
|
| 271 |
Jin X, Chen YP, Chen SH, Xiang Z. Association between Helicobacter Pylori infection and ulcerative colitis--a case control study from China. Int J Med Sci 2013;10:1479-84. [PMID: 24046521 DOI: 10.7150/ijms.6934] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 272 |
Smith SI, Fowora MA, Lesi OA, Agbebaku E, Odeigah P, Abdulkareem FB, Onyekwere CA, Agomo CA, Contreras M. Application of stool-PCR for the diagnosis of Helicobacter pylori from stool in Nigeria- a pilot study. Springerplus 2012;1:78. [PMID: 23419882 DOI: 10.1186/2193-1801-1-78] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 273 |
Kim HD, Kim do H, Park H, Kim WJ, Ahn YS, Lee YJ, Park SM, Seo ES, Park C, Kim YH. Detection of Helicobacter pylori in Gastric Aspirates Using a Monoclonal Antibody-Based Test. Gut Liver. 2013;7:30-34. [PMID: 23423538 DOI: 10.5009/gnl.2013.7.1.30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 274 |
Roccarina D, Franceschi F, Zocco MA, Garcovich M, Gasbarrini G, Gasbarrini A. Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. Dig Liver Dis 2012;44:889-92. [PMID: 22743557 DOI: 10.1016/j.dld.2012.05.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 275 |
Yoon JH, Baik GH, Kim YS, Suk KT, Shin WG, Kim KH, Kim KO, Park CH, Baik IH, Jang HJ. Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication. Gut Liver. 2012;6:434-439. [PMID: 23170146 DOI: 10.5009/gnl.2012.6.4.434] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 276 |
Najafipour R, Farivar TN, Pahlevan AA, Johari P, Safdarian F, Asefzadeh M. Agreement rate of rapid urease test, conventional PCR, and scorpion real-time PCR in detecting helicobacter pylori from tonsillar samples of patients with chronic tonsillitis. J Glob Infect Dis. 2012;4:106-109. [PMID: 22754245 DOI: 10.4103/0974-777x.96773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 277 |
Abdulqawi K, El-Mahalaway AM, Abdelhameed A, Abdelwahab AA. Correlation of serum antibody titres with invasive methods for rapid detection of Helicobacter pylori infections in symptomatic children. Int J Exp Pathol. 2012;93:295-304. [PMID: 22804766 DOI: 10.1111/j.1365-2613.2012.00831.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 278 |
Fazaeli A. State of the globe: Diagnostic tests to detect Helicobacter pylori tonsillitis. J Glob Infect Dis. 2012;4:99-101. [PMID: 22754243 DOI: 10.4103/0974-777x.96765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 279 |
Xu XQ, Wang ZH, Liao JX, Chen XY, Liu WZ, Xiao SD, Lu H. Predictive value of neutrophil infiltration as a marker of Helicobacter pylori infection. World J Gastroenterol 2012; 18(36): 5101-5105 [PMID: 23049221 DOI: 10.3748/wjg.v18.i36.5101] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 280 |
Castro M, Romero C, de Castro A, Vargas J, Medina E, Millán R, Brenes M. Assessment of Helicobacter pylori eradication by virgin olive oil. Helicobacter 2012;17:305-11. [PMID: 22759331 DOI: 10.1111/j.1523-5378.2012.00949.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 281 |
Wu W, Yang Y, Sun G. Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication. Gastroenterol Res Pract 2012;2012:723183. [PMID: 22829809 DOI: 10.1155/2012/723183] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 282 |
Iankov ID, Penheiter AR, Carlson SK, Galanis E. Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein. J Immunol Methods. 2012;384:1-9. [PMID: 22750540 DOI: 10.1016/j.jim.2012.06.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 283 |
Ramis IB, de Moraes EP, Fernandes MS, Mendoza-Sassi R, Rodrigues O, Juliano CR, Scaini CJ, da Silva PE. Evaluation of diagnostic methods for the detection of Helicobacter pylori in gastric biopsy specimens of dyspeptic patients. Braz J Microbiol. 2012;43:903-908. [PMID: 24031905 DOI: 10.1590/s1517-83822012000300008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 284 |
Choi HS, Chun HJ, Park SH, Keum B, Seo YS, Kim YS, Jeen YT, Um SH, Lee HS, Kim CD, Ryu HS. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. World J Gastroenterol 2012; 18(19): 2377-2382 [PMID: 22654429 DOI: 10.3748/wjg.v18.i19.2377] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 285 |
Rimbara E, Mori S, Matsui M, Suzuki S, Wachino J, Kawamura Y, Shen Z, Fox JG, Shibayama K. Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan. J Clin Microbiol. 2012;50:2553-2560. [PMID: 22593597 DOI: 10.1128/JCM.06810-11] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 286 |
Khan A, Farooqui A, Manzoor H, Akhtar SS, Quraishy MS, Kazmi SU. Antibiotic resistance and cagA gene correlation: A looming crisis of Helicobacter pylori. World J Gastroenterol 2012; 18(18): 2245-2252 [PMID: 22611319 DOI: 10.3748/wjg.v18.i18.2245] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 287 |
Izadi F, Ahmadi A, Ghourchian S, Daneshi A, Memari F, Khadivi E, Mohammadi S. Detection of helicobacter pylori in benign laryngeal lesions by polymerase chain reaction: a cross sectional study. Infect Agent Cancer 2012;7:10. [PMID: 22515206 DOI: 10.1186/1750-9378-7-10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 288 |
Mégraud F. The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. Therap Adv Gastroenterol 2012;5:103-9. [PMID: 22423259 DOI: 10.1177/1756283X11432492] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 289 |
Abadi AT, Taghvaei T, Mobarez AM, Carpenter BM, Merrell DS. Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran. J Microbiol 2011;49:987-93. [PMID: 22203563 DOI: 10.1007/s12275-011-1170-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 290 |
Bonacorsi C, Raddi MS, da Fonseca LM, Sannomiya M, Vilegas W. Effect of Byrsonima crassa and phenolic constituents on Helicobacter pylori-induced neutrophils oxidative burst. Int J Mol Sci 2012;13:133-41. [PMID: 22312243 DOI: 10.3390/ijms13010133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 291 |
Araújo MG, Hilário F, Nogueira LG, Vilegas W, Santos LC, Bauab TM. Chemical constituents of the methanolic extract of leaves of Leiothrix spiralis Ruhland and their antimicrobial activity. Molecules 2011;16:10479-90. [PMID: 22179427 DOI: 10.3390/molecules161210479] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 292 |
Njume C, Afolayan AJ, Samie A, Ndip RN. Inhibitory and bactericidal potential of crude acetone extracts of Combretum molle (Combretaceae) on drug-resistant strains of Helicobacter pylori. J Health Popul Nutr 2011;29:438-45. [PMID: 22106749 DOI: 10.3329/jhpn.v29i5.8897] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 293 |
Zhou D, Zhang Y, Gong W, Mohamed SO, Ogbomo H, Wang X, Liu Y, Quan Z. Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis. PLoS One. 2011;6:e27390. [PMID: 22087306 DOI: 10.1371/journal.pone.0027390] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 294 |
Kim YS, Kim SJ, Yoon JH, Suk KT, Kim JB, Kim DJ, Kim DY, Min HJ, Park SH, Shin WG, Kim KH, Kim HY, Baik GH. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther 2011;34:1098-105. [PMID: 21923713 DOI: 10.1111/j.1365-2036.2011.04843.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 295 |
Manguso F, Riccio E, de Nucci G, Aiezza ML, Amato G, Degl’Innocenti L, Piccirillo MM, De Dominicis G, Santoro T, Trimarco E, Balzano A. Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption. World J Gastroenterol 2011; 17(40): 4509-4516 [PMID: 22110282 DOI: 10.3748/wjg.v17.i40.4509] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 296 |
Lehours P, Siffré E, Mégraud F. DPO multiplex PCR as an alternative to culture and susceptibility testing to detect Helicobacter pylori and its resistance to clarithromycin. BMC Gastroenterol. 2011;11:112. [PMID: 22004003 DOI: 10.1186/1471-230x-11-112] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 297 |
Oleastro M, Pelerito A, Nogueira P, Benoliel J, Santos A, Cabral J, Lopes AI, Ramalho PM, Monteiro L. Prevalence and incidence of Helicobacter pylori Infection in a healthy pediatric population in the Lisbon area. Helicobacter 2011;16:363-72. [PMID: 21923682 DOI: 10.1111/j.1523-5378.2011.00858.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 298 |
Figueroa M, Cortés A, Pazos Á, Bravo LE. Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis. biomedica 2011;32. [DOI: 10.7705/biomedica.v32i1.454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 299 |
Njume C, Jide AA, Ndip RN. Aqueous and organic solvent-extracts of selected south African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: inhibitory and bactericidal potential. Int J Mol Sci 2011;12:5652-65. [PMID: 22016616 DOI: 10.3390/ijms12095652] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 300 |
Francesco VD, Zullo A, Hassan C, Giorgio F, Rosania R, Ierardi E. Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal. World J Gastrointest Pathophysiol 2011; 2(3): 35-41 [PMID: 21860834 DOI: 10.4291/wjgp.v2.i3.35] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 100] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 301 |
Hindler JA, Jorgensen JH. Susceptibility Test Methods: Fastidious Bacteria. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of Clinical Microbiology. Wiley; 2011. pp. 1180-203. [DOI: 10.1128/9781555816728.ch71] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 302 |
Taghvaei T, Talebi Bezmin Abadi A, Ghasemzadeh A, Naderi BK, Mohabbati Mobarez A. Prevalence of horB gene among the Helicobacter pylori strains isolated from dyspeptic patients: first report from Iran. Intern Emerg Med. 2012;7:505-508. [PMID: 21559747 DOI: 10.1007/s11739-011-0614-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 303 |
McGee DJ, George AE, Trainor EA, Horton KE, Hildebrandt E, Testerman TL. Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Antimicrob Agents Chemother. 2011;55:2897-2904. [PMID: 21464244 DOI: 10.1128/aac.00016-11] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 304 |
Talebi Bezmin Abadi A, Ghasemzadeh A, Taghvaei T, Mobarez AM. Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Intern Emerg Med. 2012;7:447-452. [PMID: 21437583 DOI: 10.1007/s11739-011-0563-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 305 |
Scholz T, Lopes VV, Calado CRC. Monitoring bacterial processes by Fourier transform infrared spectroscopy: Helicobacter pylori drug inactivation and plasmid bioproduction in recombinant Escherichia coli cultures. 1st Portuguese Biomedical Engineering Meeting 2011. [DOI: 10.1109/enbeng.2011.6026090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 306 |
Espinoza MG, Vazquez RG, Mendez IM, Vargas CR, Cerezo SG. Detection of the glmM gene in Helicobacter pylori isolates with a novel primer by PCR. J Clin Microbiol. 2011;49:1650-1652. [PMID: 21289140 DOI: 10.1128/jcm.00461-10] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 307 |
Duvnjak M, Lerotić I. Management of Helicobacter pylori Infection. Dyspepsia in Clinical Practice 2011. [DOI: 10.1007/978-1-4419-1730-0_9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 308 |
Abadi AT, Taghvaei T, Ghasemzadeh A, Mobarez AM. High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. Saudi J Gastroenterol 2011;17:396-9. [PMID: 22064338 DOI: 10.4103/1319-3767.87181] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 309 |
Oskouei DD, Bekmen N, Ellidokuz H, Yılmaz O. Evaluation of different cryoprotective agents in maintenance of viability of Helicobacter pylori in stock culture media. Braz J Microbiol 2010;41:1038-46. [PMID: 24031584 DOI: 10.1590/S1517-838220100004000023] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 310 |
Qureshi NN, Morikis D, Schiller NL. Contribution of specific amino acid changes in penicillin binding protein 1 to amoxicillin resistance in clinical Helicobacter pylori isolates. Antimicrob Agents Chemother. 2011;55:101-109. [PMID: 20956585 DOI: 10.1128/AAC.00545-10] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 311 |
Abadi AT, Taghvaei T, Vaira D. Considerable use of furazolidone in Iran. Saudi J Gastroenterol 2010;16:308-9. [PMID: 20871207 DOI: 10.4103/1319-3767.70631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 312 |
Gao W, Cheng H, Hu F, Li J, Wang L, Yang G, Xu L, Zheng X. The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China. Helicobacter 2010;15:460-6. [PMID: 21083752 DOI: 10.1111/j.1523-5378.2010.00788.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 313 |
Hwang TJ, Kim N, Kim HB, Lee BH, Nam RH, Park JH, Lee MK, Park YS, Lee DH, Jung HC, Song IS. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol 2010;44:536-43. [PMID: 20179610 DOI: 10.1097/MCG.0b013e3181d04592] [Cited by in Crossref: 103] [Cited by in F6Publishing: 110] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 314 |
Cammarota G, Branca G, Ardito F, Sanguinetti M, Ianiro G, Cianci R, Torelli R, Masala G, Gasbarrini A, Fadda G, Landolfi R, Gasbarrini G. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol 2010;8:817-820.e3. [PMID: 20478402 DOI: 10.1016/j.cgh.2010.05.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 315 |
Ramis IB, Fonseca TL, de Moraes EP, Fernandes MS, Mendoza-Sassi R, Rodrigues O, Juliano CR, Scaini CJ, da Silva PE. Molecular Basis of pathogenicity in Helicobacter pylori clinical isolates. J Clin Microbiol. 2010;48:3776-3778. [PMID: 20686086 DOI: 10.1128/jcm.00472-10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 316 |
Agudo S, Pérez-Pérez G, Alarcón T, López-Brea M. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain. J Clin Microbiol. 2010;48:3703-3707. [PMID: 20668128 DOI: 10.1128/jcm.00144-10] [Cited by in Crossref: 85] [Cited by in F6Publishing: 91] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 317 |
Qiu HB, Zhang LY, Keshari RP, Wang GQ, Zhou ZW, Xu DZ, Wang W, Zhan YQ, Li W. Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer 2010;10:374. [PMID: 20637122 DOI: 10.1186/1471-2407-10-374] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 318 |
Fonseca TL, Moraes EP, Juliano CR, Silva AM, Scaini CJ, Mendoza-Sassi RA, Silva PE. Detection of Helicobacter pylori by phenotypic and genotypic methods. Dig Dis Sci 2010;55:1643-8. [PMID: 19693671 DOI: 10.1007/s10620-009-0928-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 319 |
Cogo LL, Monteiro CL, Miguel MD, Miguel OG, Cunico MM, Ribeiro ML, de Camargo ER, Kussen GM, Nogueira Kda S, Costa LM. Anti-Helicobacter pylori activity of plant extracts traditionally used for the treatment of gastrointestinal disorders. Braz J Microbiol. 2010;41:304-309. [PMID: 24031496 DOI: 10.1590/s1517-83822010000200007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 320 |
Gisbert JP, Calvet X, O'Connor A, Mégraud F, O'Morain CA. Sequential therapy for Helicobacter pylori eradication: a critical review. J Clin Gastroenterol 2010;44:313-25. [PMID: 20054285 DOI: 10.1097/MCG.0b013e3181c8a1a3] [Cited by in Crossref: 118] [Cited by in F6Publishing: 138] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 321 |
Zheng HL, Hu YM, Bao JJ, Xu JM. Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole. Acta Pharmacol Sin 2010;31:501-8. [PMID: 20305682 DOI: 10.1038/aps.2009.191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 322 |
Ramírez FB, Torres ER, Carmona JA. Criterios actuales para la erradicación de Helicobacter pylori. FMC - Formación Médica Continuada en Atención Primaria 2010;17:158-166. [DOI: 10.1016/s1134-2072(10)70063-3] [Reference Citation Analysis]
|
| 323 |
Lee BH, Kim N, Hwang TJ, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS. Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea. Helicobacter 2010;15:38-45. [PMID: 20302588 DOI: 10.1111/j.1523-5378.2009.00735.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 324 |
Salvatore M, Meyers BR. Metronidazole. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2010. [DOI: 10.1016/b978-0-443-06839-3.00029-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 325 |
Peura DA, Crowe SE. Helicobacter pylori. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00050-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 326 |
de Korwin J, Lehours P. Helicobacter pylori : notions fondamentales, épidémiologie, méthodes diagnostiques. EMC - Gastro-entérologie 2010;5:1-16. [DOI: 10.1016/s1155-1968(10)50083-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 327 |
Kargar M, Baghernejad M, Doosti A. Role of NADPH-insensitive nitroreductase gene to metronidazole resistance of Helicobacter pylori strains. Daru 2010;18:137-40. [PMID: 22615608] [Reference Citation Analysis]
|
| 328 |
Mégraud F, Lehours P, Thijsen SF. Curved and spiral bacilli. Infectious Diseases 2010. [DOI: 10.1016/b978-0-323-04579-7.00171-4] [Reference Citation Analysis]
|
| 329 |
Lunet N, Peleteiro B, Carrilho C, Figueiredo C, Azevedo A. Sensitivity is not an intrinsic property of a diagnostic test: empirical evidence from histological diagnosis of Helicobacter pylori infection. BMC Gastroenterol. 2009;9:98. [PMID: 20034390 DOI: 10.1186/1471-230x-9-98] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 330 |
Selgrad M, Kandulski A, Malfertheiner P. Helicobacter pylori: diagnosis and treatment. Curr Opin Gastroenterol 2009;25:549-56. [PMID: 19696666 DOI: 10.1097/MOG.0b013e32833159f2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 331 |
Slinger R, Yan L, Chan F, Forward K, Cooper-Lesins G, Best L, Haldane D, Veldhuyzen van Zanten S. Pyrosequencing assay to rapidly detect clarithromycin resistance mutations in Canadian Helicobacter pylori isolates. Can J Gastroenterol 2009;23:609-12. [PMID: 19816623 DOI: 10.1155/2009/695349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 332 |
Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C, Deforges L, Soussy CJ, Delchier JC, Megraud F. Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J Clin Microbiol. 2009;47:3600-3607. [PMID: 19759218 DOI: 10.1128/jcm.00744-09] [Cited by in Crossref: 105] [Cited by in F6Publishing: 116] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 333 |
Alvarez A, Moncayo JI, Santacruz JJ, Santacoloma M, Corredor LF, Reinosa E. Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia. Antimicrob Agents Chemother 2009;53:4022-4. [PMID: 19546360 DOI: 10.1128/AAC.00145-09] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 334 |
Sisto F, Scaltrito MM, Russello G, Bonomi A, Dubini F. Antimicrobial susceptibility testing of Helicobacter pylori determined by microdilution method using a new medium. Curr Microbiol 2009;58:559-63. [PMID: 19198938 DOI: 10.1007/s00284-009-9368-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 335 |
Filipec Kanizaj T, Katicic M, Skurla B, Ticak M, Plecko V, Kalenic S. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens. Helicobacter 2009;14:29-35. [PMID: 19191893 DOI: 10.1111/j.1523-5378.2009.00656.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 336 |
Granstrom M, Lehours P, Bengtsson C, Mégraud F. Diagnosis of Helicobacter pylori. Helicobacter 2008;13 Suppl 1:7-12. [PMID: 18783515 DOI: 10.1111/j.1523-5378.2008.00637.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 337 |
Veijola L, Oksanen A, Sipponen P, Rautelin H. Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection. Clin Vaccine Immunol 2008;15:1705-10. [PMID: 18827192 DOI: 10.1128/CVI.00165-08] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 338 |
Burucoa C, Garnier M, Silvain C, Fauchère JL. Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J Clin Microbiol. 2008;46:2320-2326. [PMID: 18463216 DOI: 10.1128/jcm.02352-07] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 339 |
Dong J, Olano JP, McBride JW, Walker DH. Emerging pathogens: challenges and successes of molecular diagnostics. J Mol Diagn 2008;10:185-97. [PMID: 18403608 DOI: 10.2353/jmoldx.2008.070063] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 340 |
Raymond J, Lamarque D. Diagnostic de l'infection à Helicobacter pylori. Revue Francophone des Laboratoires 2008;2008:36-38. [DOI: 10.1016/s1773-035x(08)80055-x] [Reference Citation Analysis]
|
| 341 |
Enroth H, Engstrand L. Helicobacter Pylori. International Encyclopedia of Public Health 2008. [DOI: 10.1016/b978-012373960-5.00588-8] [Reference Citation Analysis]
|
| 342 |
Pietroiusti A, Forlini A, Magrini A, Galante A, Bergamaschi A. Isolated H. pylori duodenal colonization and idiopathic duodenal ulcers. Am J Gastroenterol 2008;103:55-61. [PMID: 17764496 DOI: 10.1111/j.1572-0241.2007.01506.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 343 |
Yilmaz O. Progress in developing accurate tests for the diagnosis of Helicobacter pylori infection. Expert Opin Med Diagn 2007;1:531-40. [PMID: 23496359 DOI: 10.1517/17530059.1.4.531] [Reference Citation Analysis]
|
| 344 |
Hirschl AM, Makristathis A. Methods to detect Helicobacter pylori: from culture to molecular biology. Helicobacter 2007;12 Suppl 2:6-11. [PMID: 17991170 DOI: 10.1111/j.1523-5378.2007.00560.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 345 |
Egan BJ, Katicic M, O'Connor HJ, O'Morain CA. Treatment of Helicobacter pylori. Helicobacter 2007;12 Suppl 1:31-7. [PMID: 17727458 DOI: 10.1111/j.1523-5378.2007.00538.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 346 |
Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007;133:985-1001. [PMID: 17854602 DOI: 10.1053/j.gastro.2007.07.008] [Cited by in Crossref: 168] [Cited by in F6Publishing: 176] [Article Influence: 10.5] [Reference Citation Analysis]
|
